KEGG   ORTHOLOGY: K08041
Entry
K08041                      KO                                     

Name
ADCY1
Definition
adenylate cyclase 1 [EC:4.6.1.1]
Pathway
ko00230  Purine metabolism
ko01100  Metabolic pathways
ko01522  Endocrine resistance
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04062  Chemokine signaling pathway
ko04072  Phospholipase D signaling pathway
ko04114  Oocyte meiosis
ko04211  Longevity regulating pathway
ko04213  Longevity regulating pathway - multiple species
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04371  Apelin signaling pathway
ko04540  Gap junction
ko04611  Platelet activation
ko04713  Circadian entrainment
ko04714  Thermogenesis
ko04720  Long-term potentiation
ko04723  Retrograde endocannabinoid signaling
ko04724  Glutamatergic synapse
ko04725  Cholinergic synapse
ko04727  GABAergic synapse
ko04750  Inflammatory mediator regulation of TRP channels
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04913  Ovarian steroidogenesis
ko04914  Progesterone-mediated oocyte maturation
ko04915  Estrogen signaling pathway
ko04916  Melanogenesis
ko04918  Thyroid hormone synthesis
ko04921  Oxytocin signaling pathway
ko04923  Regulation of lipolysis in adipocytes
ko04925  Aldosterone synthesis and secretion
ko04926  Relaxin signaling pathway
ko04927  Cortisol synthesis and secretion
ko04928  Parathyroid hormone synthesis, secretion and action
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko04970  Salivary secretion
ko04971  Gastric acid secretion
ko04972  Pancreatic secretion
ko04976  Bile secretion
ko05032  Morphine addiction
ko05142  Chagas disease
ko05146  Amoebiasis
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05200  Pathways in cancer
ko05207  Chemical carcinogenesis - receptor activation
ko05414  Dilated cardiomyopathy
Disease
H00605  Deafness, autosomal recessive
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09104 Nucleotide metabolism
   00230 Purine metabolism
    K08041  ADCY1; adenylate cyclase 1
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K08041  ADCY1; adenylate cyclase 1
   04371 Apelin signaling pathway
    K08041  ADCY1; adenylate cyclase 1
   04020 Calcium signaling pathway
    K08041  ADCY1; adenylate cyclase 1
   04072 Phospholipase D signaling pathway
    K08041  ADCY1; adenylate cyclase 1
   04024 cAMP signaling pathway
    K08041  ADCY1; adenylate cyclase 1
   04022 cGMP-PKG signaling pathway
    K08041  ADCY1; adenylate cyclase 1
 09140 Cellular Processes
  09143 Cell growth and death
   04114 Oocyte meiosis
    K08041  ADCY1; adenylate cyclase 1
  09144 Cellular community - eukaryotes
   04540 Gap junction
    K08041  ADCY1; adenylate cyclase 1
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    K08041  ADCY1; adenylate cyclase 1
   04062 Chemokine signaling pathway
    K08041  ADCY1; adenylate cyclase 1
  09152 Endocrine system
   04911 Insulin secretion
    K08041  ADCY1; adenylate cyclase 1
   04923 Regulation of lipolysis in adipocytes
    K08041  ADCY1; adenylate cyclase 1
   04912 GnRH signaling pathway
    K08041  ADCY1; adenylate cyclase 1
   04913 Ovarian steroidogenesis
    K08041  ADCY1; adenylate cyclase 1
   04915 Estrogen signaling pathway
    K08041  ADCY1; adenylate cyclase 1
   04914 Progesterone-mediated oocyte maturation
    K08041  ADCY1; adenylate cyclase 1
   04921 Oxytocin signaling pathway
    K08041  ADCY1; adenylate cyclase 1
   04926 Relaxin signaling pathway
    K08041  ADCY1; adenylate cyclase 1
   04935 Growth hormone synthesis, secretion and action
    K08041  ADCY1; adenylate cyclase 1
   04918 Thyroid hormone synthesis
    K08041  ADCY1; adenylate cyclase 1
   04928 Parathyroid hormone synthesis, secretion and action
    K08041  ADCY1; adenylate cyclase 1
   04916 Melanogenesis
    K08041  ADCY1; adenylate cyclase 1
   04925 Aldosterone synthesis and secretion
    K08041  ADCY1; adenylate cyclase 1
   04927 Cortisol synthesis and secretion
    K08041  ADCY1; adenylate cyclase 1
  09153 Circulatory system
   04261 Adrenergic signaling in cardiomyocytes
    K08041  ADCY1; adenylate cyclase 1
   04270 Vascular smooth muscle contraction
    K08041  ADCY1; adenylate cyclase 1
  09154 Digestive system
   04970 Salivary secretion
    K08041  ADCY1; adenylate cyclase 1
   04971 Gastric acid secretion
    K08041  ADCY1; adenylate cyclase 1
   04972 Pancreatic secretion
    K08041  ADCY1; adenylate cyclase 1
   04976 Bile secretion
    K08041  ADCY1; adenylate cyclase 1
  09156 Nervous system
   04724 Glutamatergic synapse
    K08041  ADCY1; adenylate cyclase 1
   04727 GABAergic synapse
    K08041  ADCY1; adenylate cyclase 1
   04725 Cholinergic synapse
    K08041  ADCY1; adenylate cyclase 1
   04720 Long-term potentiation
    K08041  ADCY1; adenylate cyclase 1
   04723 Retrograde endocannabinoid signaling
    K08041  ADCY1; adenylate cyclase 1
  09157 Sensory system
   04750 Inflammatory mediator regulation of TRP channels
    K08041  ADCY1; adenylate cyclase 1
  09149 Aging
   04211 Longevity regulating pathway
    K08041  ADCY1; adenylate cyclase 1
   04213 Longevity regulating pathway - multiple species
    K08041  ADCY1; adenylate cyclase 1
  09159 Environmental adaptation
   04713 Circadian entrainment
    K08041  ADCY1; adenylate cyclase 1
   04714 Thermogenesis
    K08041  ADCY1; adenylate cyclase 1
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K08041  ADCY1; adenylate cyclase 1
   05207 Chemical carcinogenesis - receptor activation
    K08041  ADCY1; adenylate cyclase 1
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K08041  ADCY1; adenylate cyclase 1
   05163 Human cytomegalovirus infection
    K08041  ADCY1; adenylate cyclase 1
  09174 Infectious disease: parasitic
   05146 Amoebiasis
    K08041  ADCY1; adenylate cyclase 1
   05142 Chagas disease
    K08041  ADCY1; adenylate cyclase 1
  09165 Substance dependence
   05032 Morphine addiction
    K08041  ADCY1; adenylate cyclase 1
  09166 Cardiovascular disease
   05414 Dilated cardiomyopathy
    K08041  ADCY1; adenylate cyclase 1
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K08041  ADCY1; adenylate cyclase 1
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K08041  ADCY1; adenylate cyclase 1
Enzymes [BR:ko01000]
 4. Lyases
  4.6  Phosphorus-oxygen lyases
   4.6.1  Phosphorus-oxygen lyases (only sub-subclass identified to date)
    4.6.1.1  adenylate cyclase
     K08041  ADCY1; adenylate cyclase 1
Other DBs
RN: R00089 R00434
GO: 0008294
Genes
HSA: 107(ADCY1)
PTR: 463392(ADCY1)
PPS: 100984585(ADCY1)
GGO: 101125943(ADCY1)
PON: 100449504(ADCY1)
NLE: 100595636(ADCY1)
MCC: 697230(ADCY1)
MCF: 102147015(ADCY1)
CSAB: 103226115(ADCY1)
CATY: 105588320(ADCY1)
RRO: 104671165(ADCY1)
RBB: 108534793(ADCY1)
TFN: 117073333(ADCY1)
CJC: 100394265(ADCY1)
SBQ: 101027981(ADCY1)
MMUR: 105870668(ADCY1)
MMU: 432530(Adcy1)
MCAL: 110305998(Adcy1)
MPAH: 110330584(Adcy1)
RNO: 305509(Adcy1)
MCOC: 116069116(Adcy1)
MUN: 110555169(Adcy1)
CGE: 100764561(Adcy1)
PLEU: 114693962(Adcy1)
NGI: 103741433(Adcy1)
HGL: 101711366(Adcy1)
CCAN: 109694874(Adcy1)
TUP: 102468873(ADCY1)
CFA: 607357(ADCY1)
VVP: 112911455(ADCY1)
VLG: 121490100(ADCY1) 121492610
AML: 100472777(ADCY1)
UAH: 113257705(ADCY1)
ORO: 101379158(ADCY1)
ELK: 111157054
MPUF: 101676834(ADCY1)
EJU: 114213699(ADCY1)
FCA: 101101375(ADCY1)
PTG: 102961712(ADCY1)
PPAD: 109267948(ADCY1)
AJU: 106968223(ADCY1)
HHV: 120238897(ADCY1)
BTA: 281601(ADCY1)
BOM: 102267116(ADCY1)
BIU: 109557525(ADCY1)
BBUB: 102415323(ADCY1)
CHX: 102180724(ADCY1)
OAS: 101117327(ADCY1)
ODA: 120877473(ADCY1)
SSC: 100624934(ADCY1)
CFR: 102517882(ADCY1)
CDK: 105095715(ADCY1)
BACU: 102998650(ADCY1)
LVE: 103081539(ADCY1)
OOR: 101278368(ADCY1)
DLE: 111184534(ADCY1)
PCAD: 102981199(ADCY1)
ECB: 100065563(ADCY1)
EPZ: 103550430(ADCY1)
EAI: 106822932(ADCY1)
MYB: 102257679(ADCY1)
MYD: 102759978(ADCY1)
MMYO: 118665883(ADCY1)
MNA: 107526004(ADCY1)
HAI: 109373011(ADCY1)
DRO: 112306844(ADCY1)
SHON: 118983483(ADCY1)
AJM: 119057313(ADCY1)
MMF: 118620164(ADCY1)
PALE: 102887497(ADCY1)
RAY: 107512406(ADCY1)
MJV: 108403511(ADCY1)
LAV: 100671072(ADCY1)
TMU: 101354868
MDO: 100030463(ADCY1)
SHR: 100922193(ADCY1)
PCW: 110197533(ADCY1)
OAA: 103168601(ADCY1)
GGA: 420788(ADCY1)
PCOC: 116228264(ADCY1)
CJO: 107309766(ADCY1)
NMEL: 110390836(ADCY1)
APLA: 101804073(ADCY1)
ACYG: 106046455(ADCY1)
TGU: 100226080(ADCY1)
LSR: 110477391(ADCY1)
SCAN: 103819377(ADCY1)
PMOA: 120503563(ADCY1)
GFR: 102040399(ADCY1)
FAB: 101807752(ADCY1)
PHI: 102110269(ADCY1)
PMAJ: 107201036(ADCY1)
CCAE: 111923918(ADCY1)
CCW: 104689252(ADCY1)
ETL: 114068677(ADCY1)
FPG: 101914769(ADCY1)
FCH: 102056699(ADCY1)
CLV: 102094612(ADCY1)
EGZ: 104125965(ADCY1)
NNI: 104015394(ADCY1)
ACUN: 113477314(ADCY1)
PADL: 103916246(ADCY1)
AAM: 106492856(ADCY1)
ASN: 102372645(ADCY1)
AMJ: 102573818(ADCY1)
CPOO: 109310610(ADCY1)
GGN: 109291654(ADCY1)
PSS: 102445759(ADCY1)
CMY: 102939135(ADCY1)
CPIC: 101935286(ADCY1)
TST: 117872635(ADCY1)
CABI: 116834610(ADCY1)
ACS: 100564004(adcy1)
PVT: 110091617(ADCY1)
PBI: 103068192
PMUR: 107287848(ADCY1)
TSR: 106543976(ADCY1)
PGUT: 117664957(ADCY1)
PMUA: 114607043(ADCY1)
ZVI: 118077681(ADCY1)
GJA: 107119176(ADCY1)
XLA: 108705348(adcy1.S) 108718988(adcy1.L)
XTR: 100492373(adcy1)
NPR: 108796974(ADCY1)
DRE: 557026(adcy1a) 569499(adcy1b)
IPU: 108257925 108267157(adcy1)
PHYP: 113545185 113547307(adcy1)
TRU: 101074661(adcy1)
NCC: 104962323
OAU: 116314396(adcy1a) 116318699
OML: 112147429(adcy1a) 112150580
POV: 109637504(adcy1) 109643317
BPEC: 110159474(adcy1) 110172262
LOC: 102692556(adcy1)
CMK: 103187011(adcy1)
RTP: 109910491
DME: Dmel_CG9533(rut)
DER: 6550736
DSE: 6619554
DSI: Dsimw501_GD15838(Dsim_rut)
DAN: 6504270
DSR: 110182103
DPE: 6598394
DMN: 108161375
DWI: 6653130
DAZ: 108618185
DNV: 108656529
DHE: 111600202
DVI: 6631926
MDE: 101890662
LCQ: 111684525
ACOZ: 120959989
AARA: 120906721
AAG: 5571379
AALB: 109401880
CPII: 120420252
TCA: 661438(rut)
DPA: 109546607
AGB: 108904553
NVL: 108566779
APLN: 108736715
PPYR: 116176544
OTU: 111427516
BMOR: 101741402
BMAN: 114248717
MSEX: 115454133
PMAC: 106720337
PPOT: 106109142
PXU: 106127108
PRAP: 110991594
ZCE: 119834784
HAW: 110369899
TNL: 113501500
PXY: 105380532
API: 100164676
DNX: 107168960
AGS: 114126041
RMD: 113559605
BTAB: 109030117
DCI: 103514692
CLEC: 106662482
NLU: 111062756
ZNE: 110826860
CSEC: 111871901
FCD: 110861546
DPX: DAPPUDRAFT_48469(Adcy2)
PVM: 113821369
EAF: 111709929
DSV: 119442413
RSAN: 119386353
RMP: 119159511
TUT: 107360550
DPTE: 113792109
CSCU: 111626639
PTEP: 107453371
SDM: 118191600
PCAN: 112564559
BGT: 106067245
GAE: 121380643
MYI: 110465124
PMAX: 117343252
OBI: 106868905
LAK: 106159379
 » show all
Reference
PMID:9662407
  Authors
Abdel-Majid RM, Leong WL, Schalkwyk LC, Smallman DS, Wong ST, Storm DR, Fine A, Dobson MJ, Guernsey DL, Neumann PE
  Title
Loss of adenylyl cyclase I activity disrupts patterning of mouse somatosensory cortex.
  Journal
Nat Genet 19:289-91 (1998)
DOI:10.1038/980
  Sequence
[mmu:432530]
Reference
PMID:8314585
  Authors
Villacres EC, Xia Z, Bookbinder LH, Edelhoff S, Disteche CM, Storm DR
  Title
Cloning, chromosomal mapping, and expression of human fetal brain type I adenylyl cyclase.
  Journal
Genomics 16:473-8 (1993)
DOI:10.1006/geno.1993.1213
  Sequence
[hsa:107]
LinkDB

KEGG   ORTHOLOGY: K08042
Entry
K08042                      KO                                     

Name
ADCY2
Definition
adenylate cyclase 2 [EC:4.6.1.1]
Pathway
ko00230  Purine metabolism
ko01100  Metabolic pathways
ko01522  Endocrine resistance
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04062  Chemokine signaling pathway
ko04072  Phospholipase D signaling pathway
ko04114  Oocyte meiosis
ko04211  Longevity regulating pathway
ko04213  Longevity regulating pathway - multiple species
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04371  Apelin signaling pathway
ko04540  Gap junction
ko04611  Platelet activation
ko04713  Circadian entrainment
ko04714  Thermogenesis
ko04723  Retrograde endocannabinoid signaling
ko04724  Glutamatergic synapse
ko04725  Cholinergic synapse
ko04727  GABAergic synapse
ko04750  Inflammatory mediator regulation of TRP channels
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04913  Ovarian steroidogenesis
ko04914  Progesterone-mediated oocyte maturation
ko04915  Estrogen signaling pathway
ko04916  Melanogenesis
ko04918  Thyroid hormone synthesis
ko04921  Oxytocin signaling pathway
ko04922  Glucagon signaling pathway
ko04923  Regulation of lipolysis in adipocytes
ko04925  Aldosterone synthesis and secretion
ko04926  Relaxin signaling pathway
ko04927  Cortisol synthesis and secretion
ko04928  Parathyroid hormone synthesis, secretion and action
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko04970  Salivary secretion
ko04971  Gastric acid secretion
ko04972  Pancreatic secretion
ko04976  Bile secretion
ko05032  Morphine addiction
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05200  Pathways in cancer
ko05207  Chemical carcinogenesis - receptor activation
ko05414  Dilated cardiomyopathy
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09104 Nucleotide metabolism
   00230 Purine metabolism
    K08042  ADCY2; adenylate cyclase 2
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K08042  ADCY2; adenylate cyclase 2
   04371 Apelin signaling pathway
    K08042  ADCY2; adenylate cyclase 2
   04020 Calcium signaling pathway
    K08042  ADCY2; adenylate cyclase 2
   04072 Phospholipase D signaling pathway
    K08042  ADCY2; adenylate cyclase 2
   04024 cAMP signaling pathway
    K08042  ADCY2; adenylate cyclase 2
   04022 cGMP-PKG signaling pathway
    K08042  ADCY2; adenylate cyclase 2
 09140 Cellular Processes
  09143 Cell growth and death
   04114 Oocyte meiosis
    K08042  ADCY2; adenylate cyclase 2
  09144 Cellular community - eukaryotes
   04540 Gap junction
    K08042  ADCY2; adenylate cyclase 2
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    K08042  ADCY2; adenylate cyclase 2
   04062 Chemokine signaling pathway
    K08042  ADCY2; adenylate cyclase 2
  09152 Endocrine system
   04911 Insulin secretion
    K08042  ADCY2; adenylate cyclase 2
   04922 Glucagon signaling pathway
    K08042  ADCY2; adenylate cyclase 2
   04923 Regulation of lipolysis in adipocytes
    K08042  ADCY2; adenylate cyclase 2
   04912 GnRH signaling pathway
    K08042  ADCY2; adenylate cyclase 2
   04913 Ovarian steroidogenesis
    K08042  ADCY2; adenylate cyclase 2
   04915 Estrogen signaling pathway
    K08042  ADCY2; adenylate cyclase 2
   04914 Progesterone-mediated oocyte maturation
    K08042  ADCY2; adenylate cyclase 2
   04921 Oxytocin signaling pathway
    K08042  ADCY2; adenylate cyclase 2
   04926 Relaxin signaling pathway
    K08042  ADCY2; adenylate cyclase 2
   04935 Growth hormone synthesis, secretion and action
    K08042  ADCY2; adenylate cyclase 2
   04918 Thyroid hormone synthesis
    K08042  ADCY2; adenylate cyclase 2
   04928 Parathyroid hormone synthesis, secretion and action
    K08042  ADCY2; adenylate cyclase 2
   04916 Melanogenesis
    K08042  ADCY2; adenylate cyclase 2
   04925 Aldosterone synthesis and secretion
    K08042  ADCY2; adenylate cyclase 2
   04927 Cortisol synthesis and secretion
    K08042  ADCY2; adenylate cyclase 2
  09153 Circulatory system
   04261 Adrenergic signaling in cardiomyocytes
    K08042  ADCY2; adenylate cyclase 2
   04270 Vascular smooth muscle contraction
    K08042  ADCY2; adenylate cyclase 2
  09154 Digestive system
   04970 Salivary secretion
    K08042  ADCY2; adenylate cyclase 2
   04971 Gastric acid secretion
    K08042  ADCY2; adenylate cyclase 2
   04972 Pancreatic secretion
    K08042  ADCY2; adenylate cyclase 2
   04976 Bile secretion
    K08042  ADCY2; adenylate cyclase 2
  09156 Nervous system
   04724 Glutamatergic synapse
    K08042  ADCY2; adenylate cyclase 2
   04727 GABAergic synapse
    K08042  ADCY2; adenylate cyclase 2
   04725 Cholinergic synapse
    K08042  ADCY2; adenylate cyclase 2
   04723 Retrograde endocannabinoid signaling
    K08042  ADCY2; adenylate cyclase 2
  09157 Sensory system
   04750 Inflammatory mediator regulation of TRP channels
    K08042  ADCY2; adenylate cyclase 2
  09149 Aging
   04211 Longevity regulating pathway
    K08042  ADCY2; adenylate cyclase 2
   04213 Longevity regulating pathway - multiple species
    K08042  ADCY2; adenylate cyclase 2
  09159 Environmental adaptation
   04713 Circadian entrainment
    K08042  ADCY2; adenylate cyclase 2
   04714 Thermogenesis
    K08042  ADCY2; adenylate cyclase 2
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K08042  ADCY2; adenylate cyclase 2
   05207 Chemical carcinogenesis - receptor activation
    K08042  ADCY2; adenylate cyclase 2
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K08042  ADCY2; adenylate cyclase 2
   05163 Human cytomegalovirus infection
    K08042  ADCY2; adenylate cyclase 2
  09165 Substance dependence
   05032 Morphine addiction
    K08042  ADCY2; adenylate cyclase 2
  09166 Cardiovascular disease
   05414 Dilated cardiomyopathy
    K08042  ADCY2; adenylate cyclase 2
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K08042  ADCY2; adenylate cyclase 2
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K08042  ADCY2; adenylate cyclase 2
Enzymes [BR:ko01000]
 4. Lyases
  4.6  Phosphorus-oxygen lyases
   4.6.1  Phosphorus-oxygen lyases (only sub-subclass identified to date)
    4.6.1.1  adenylate cyclase
     K08042  ADCY2; adenylate cyclase 2
Other DBs
RN: R00089 R00434
GO: 0004016
Genes
HSA: 108(ADCY2)
PTR: 100608010(ADCY2)
PPS: 100992014(ADCY2)
GGO: 101141389(ADCY2)
PON: 100445431(ADCY2)
NLE: 100600367(ADCY2)
MCC: 695328(ADCY2)
MCF: 102130114(ADCY2)
CSAB: 103214981(ADCY2)
CATY: 105585972(ADCY2)
RRO: 104674083(ADCY2)
RBB: 108536960(ADCY2)
TFN: 117064735(ADCY2)
CJC: 100385658(ADCY2)
SBQ: 101043334(ADCY2)
MMUR: 105859934(ADCY2)
MMU: 210044(Adcy2)
MCAL: 110307661(Adcy2)
MPAH: 110328764(Adcy2)
RNO: 81636(Adcy2)
MCOC: 116083593(Adcy2)
MUN: 110550962
CGE: 100773811(Adcy2)
PLEU: 114696121(Adcy2)
NGI: 103735350(Adcy2)
HGL: 101718304(Adcy2)
CCAN: 109695818(Adcy2)
OCU: 100009201(ADCY2)
TUP: 102492353(ADCY2)
CFA: 478624(ADCY2)
VVP: 112934273(ADCY2)
VLG: 121477531(ADCY2)
AML: 100473195(ADCY2)
UMR: 103679250(ADCY2)
UAH: 113260807(ADCY2)
ORO: 101365382(ADCY2)
ELK: 111153427
MPUF: 101674868(ADCY2)
EJU: 114223681(ADCY2)
FCA: 101094327(ADCY2)
PTG: 102949732(ADCY2)
PPAD: 109267830(ADCY2)
AJU: 106971248(ADCY2)
HHV: 120225093(ADCY2)
BTA: 510708(ADCY2)
BOM: 102274117(ADCY2)
BIU: 109574822(ADCY2)
BBUB: 102412622(ADCY2)
CHX: 102171922(ADCY2)
OAS: 101102089(ADCY2)
ODA: 120879368(ADCY2)
SSC: 100517503(ADCY2)
CFR: 102510993(ADCY2)
CDK: 105094039(ADCY2)
BACU: 103020085(ADCY2)
LVE: 103084817(ADCY2)
OOR: 101286207(ADCY2)
DLE: 111178556(ADCY2)
PCAD: 102991224(ADCY2)
ECB: 100071337(ADCY2)
EPZ: 103562505
EAI: 106823001(ADCY2)
MYB: 102260356(ADCY2)
MYD: 102774384(ADCY2)
MMYO: 118656192(ADCY2)
MNA: 107540528(ADCY2)
HAI: 109375976(ADCY2)
DRO: 112321008(ADCY2)
SHON: 118998674(ADCY2)
AJM: 119049317(ADCY2)
MMF: 118642779(ADCY2)
PALE: 102893265(ADCY2)
RAY: 107502700(ADCY2)
LAV: 100673570(ADCY2)
TMU: 101360334
MDO: 100013164(ADCY2)
SHR: 100922434(ADCY2)
PCW: 110220436(ADCY2)
OAA: 100089708(ADCY2)
GGA: 420935(ADCY2)
PCOC: 116226507(ADCY2)
MGP: 100540738(ADCY2)
CJO: 107309543(ADCY2)
NMEL: 110394300(ADCY2)
APLA: 101803512(ADCY2)
ACYG: 106036531(ADCY2)
TGU: 100223820(ADCY2)
LSR: 110479527(ADCY2)
SCAN: 103815408(ADCY2)
PMOA: 120504898(ADCY2)
GFR: 102038853(ADCY2)
FAB: 101808400(ADCY2)
PHI: 102113898(ADCY2)
PMAJ: 107199935(ADCY2)
CCAE: 111925673(ADCY2)
CCW: 104685925(ADCY2)
ETL: 114055132(ADCY2)
FPG: 101911647(ADCY2)
FCH: 102049688(ADCY2)
CLV: 102097532(ADCY2)
EGZ: 104126191(ADCY2)
NNI: 104018888(ADCY2)
ACUN: 113476067(ADCY2)
PADL: 103915154(ADCY2)
AAM: 106492356(ADCY2)
ASN: 102383838(ADCY2)
AMJ: 102562034(ADCY2)
CPOO: 109314286(ADCY2)
GGN: 109298362(ADCY2)
PSS: 102444057(ADCY2)
CMY: 102930552(ADCY2)
CPIC: 101952054(ADCY2)
TST: 117872756
CABI: 116828360(ADCY2)
ACS: 100555265(adcy2)
PVT: 110089596
PBI: 103050340(ADCY2)
PMUR: 107297625(ADCY2)
TSR: 106545186
PGUT: 117662380(ADCY2)
PMUA: 114601220(ADCY2)
ZVI: 118077623(ADCY2)
GJA: 107108835(ADCY2)
DRE: 557902(adcy2b) 563724(adcy2a)
IPU: 108272199(Adcy2) 108272792(ADCY2)
NCC: 104952475 104962256(adcy2)
ELY: 117263948(adcy2b) 117265672(adcy2a)
PLEP: 121946261(adcy2a) 121957695(adcy2b)
SLUC: 116041211(adcy2b) 116049201(adcy2a)
MSAM: 119897894(adcy2a) 119907366(adcy2b)
OAU: 116313447(adcy2b) 116329362(adcy2a)
OML: 112136286(adcy2b) 112143511(adcy2a)
XCO: 114141804 114156097(adcy2)
CVG: 107084393 107091823(adcy2)
KMR: 108232311(adcy2a) 108238708(adcy2b)
POV: 109631507(adcy2) 109632042
XGL: 120783631(adcy2a) 120786774(adcy2b)
HCQ: 109508262 109521934(adcy2)
OTW: 112229303(adcy2) 112265839
SALP: 111954801(adcy2) 111955524
ELS: 105012408(adcy2)
LOC: 102696921(adcy2)
CMK: 103183192(adcy2)
RTP: 109920424(adcy2)
BFO: 118417332
SPU: 575180
APLC: 110980095
SKO: 102803250
DME: Dmel_CG7978(Ac76E)
DER: 6545709
DSE: 6619425
DSI: Dsimw501_GD14841(Dsim_GD14841)
DAN: 6506248
DSR: 110189922
DPE: 6599071
DMN: 108152507
DWI: 6638793
DAZ: 108614292
DNV: 108651863
DHE: 111604449
DVI: 6622821
MDE: 101893904
LCQ: 111683625
ACOZ: 120955519
AARA: 120900861
AAG: 5571159
AALB: 109418769
CPII: 120425270
AME: 552216
BIM: 100745521
BTER: 100647623
CCAL: 108631101
OBB: 114880740
MGEN: 117228009
NMEA: 116428151
SOC: 105197184
MPHA: 105835065
AEC: 105143483
ACEP: 105617405
PBAR: 105425936
VEM: 105559069
HST: 105184375
DQU: 106746346
CFO: 105250746
FEX: 115233348
LHU: 105670932
PGC: 109855918
OBO: 105285379
PCF: 106792130
NVI: 100118148
CSOL: 105367877
MDL: 103577402
TCA: 660403
ATD: 109608976
NVL: 108567526
OTU: 111424772
BMOR: 101737606
BMAN: 114243277
MSEX: 115452886
PMAC: 106718962
PXU: 106121310
PRAP: 110995397
ZCE: 119840764
HAW: 110373694
TNL: 113497935
API: 100164066
DNX: 107167195
AGS: 114123846
RMD: 113553384
BTAB: 109030143
DCI: 103508920
CLEC: 106667432
NLU: 111045768
ZNE: 110829129
FCD: 110849688
PVM: 113818924
DSV: 119436082
RSAN: 119372661
RMP: 119185511
VDE: 111251320
VJA: 111272620
PTEP: 107452662
PCAN: 112577004
BGT: 106067294
GAE: 121388686
CRG: 105336030
MYI: 110458458
PMAX: 117337564
 » show all
Reference
PMID:1427768
  Authors
Stengel D, Parma J, Gannage MH, Roeckel N, Mattei MG, Barouki R, Hanoune J
  Title
Different chromosomal localization of two adenylyl cyclase genes expressed in human brain.
  Journal
Hum Genet 90:126-30 (1992)
DOI:10.1007/BF00210755
  Sequence
[hsa:108]
Reference
  Authors
Hardin M, Zielinski J, Wan ES, Hersh CP, Castaldi PJ, Schwinder E, Hawrylkiewicz I, Sliwinski P, Cho MH, Silverman EK
  Title
CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland.
  Journal
Am J Respir Cell Mol Biol 47:203-8 (2012)
DOI:10.1165/rcmb.2012-0011OC
LinkDB

KEGG   ORTHOLOGY: K08043
Entry
K08043                      KO                                     

Name
ADCY3
Definition
adenylate cyclase 3 [EC:4.6.1.1]
Pathway
ko00230  Purine metabolism
ko01100  Metabolic pathways
ko01522  Endocrine resistance
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04062  Chemokine signaling pathway
ko04072  Phospholipase D signaling pathway
ko04114  Oocyte meiosis
ko04211  Longevity regulating pathway
ko04213  Longevity regulating pathway - multiple species
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04371  Apelin signaling pathway
ko04540  Gap junction
ko04611  Platelet activation
ko04713  Circadian entrainment
ko04714  Thermogenesis
ko04723  Retrograde endocannabinoid signaling
ko04724  Glutamatergic synapse
ko04725  Cholinergic synapse
ko04727  GABAergic synapse
ko04740  Olfactory transduction
ko04750  Inflammatory mediator regulation of TRP channels
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04913  Ovarian steroidogenesis
ko04914  Progesterone-mediated oocyte maturation
ko04915  Estrogen signaling pathway
ko04916  Melanogenesis
ko04918  Thyroid hormone synthesis
ko04921  Oxytocin signaling pathway
ko04923  Regulation of lipolysis in adipocytes
ko04925  Aldosterone synthesis and secretion
ko04926  Relaxin signaling pathway
ko04927  Cortisol synthesis and secretion
ko04928  Parathyroid hormone synthesis, secretion and action
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko04962  Vasopressin-regulated water reabsorption
ko04970  Salivary secretion
ko04971  Gastric acid secretion
ko04972  Pancreatic secretion
ko04976  Bile secretion
ko05032  Morphine addiction
ko05110  Vibrio cholerae infection
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05200  Pathways in cancer
ko05207  Chemical carcinogenesis - receptor activation
ko05414  Dilated cardiomyopathy
Disease
H02106  Genetic obesity
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09104 Nucleotide metabolism
   00230 Purine metabolism
    K08043  ADCY3; adenylate cyclase 3
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K08043  ADCY3; adenylate cyclase 3
   04371 Apelin signaling pathway
    K08043  ADCY3; adenylate cyclase 3
   04020 Calcium signaling pathway
    K08043  ADCY3; adenylate cyclase 3
   04072 Phospholipase D signaling pathway
    K08043  ADCY3; adenylate cyclase 3
   04024 cAMP signaling pathway
    K08043  ADCY3; adenylate cyclase 3
   04022 cGMP-PKG signaling pathway
    K08043  ADCY3; adenylate cyclase 3
 09140 Cellular Processes
  09143 Cell growth and death
   04114 Oocyte meiosis
    K08043  ADCY3; adenylate cyclase 3
  09144 Cellular community - eukaryotes
   04540 Gap junction
    K08043  ADCY3; adenylate cyclase 3
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    K08043  ADCY3; adenylate cyclase 3
   04062 Chemokine signaling pathway
    K08043  ADCY3; adenylate cyclase 3
  09152 Endocrine system
   04911 Insulin secretion
    K08043  ADCY3; adenylate cyclase 3
   04923 Regulation of lipolysis in adipocytes
    K08043  ADCY3; adenylate cyclase 3
   04912 GnRH signaling pathway
    K08043  ADCY3; adenylate cyclase 3
   04913 Ovarian steroidogenesis
    K08043  ADCY3; adenylate cyclase 3
   04915 Estrogen signaling pathway
    K08043  ADCY3; adenylate cyclase 3
   04914 Progesterone-mediated oocyte maturation
    K08043  ADCY3; adenylate cyclase 3
   04921 Oxytocin signaling pathway
    K08043  ADCY3; adenylate cyclase 3
   04926 Relaxin signaling pathway
    K08043  ADCY3; adenylate cyclase 3
   04935 Growth hormone synthesis, secretion and action
    K08043  ADCY3; adenylate cyclase 3
   04918 Thyroid hormone synthesis
    K08043  ADCY3; adenylate cyclase 3
   04928 Parathyroid hormone synthesis, secretion and action
    K08043  ADCY3; adenylate cyclase 3
   04916 Melanogenesis
    K08043  ADCY3; adenylate cyclase 3
   04925 Aldosterone synthesis and secretion
    K08043  ADCY3; adenylate cyclase 3
   04927 Cortisol synthesis and secretion
    K08043  ADCY3; adenylate cyclase 3
  09153 Circulatory system
   04261 Adrenergic signaling in cardiomyocytes
    K08043  ADCY3; adenylate cyclase 3
   04270 Vascular smooth muscle contraction
    K08043  ADCY3; adenylate cyclase 3
  09154 Digestive system
   04970 Salivary secretion
    K08043  ADCY3; adenylate cyclase 3
   04971 Gastric acid secretion
    K08043  ADCY3; adenylate cyclase 3
   04972 Pancreatic secretion
    K08043  ADCY3; adenylate cyclase 3
   04976 Bile secretion
    K08043  ADCY3; adenylate cyclase 3
  09155 Excretory system
   04962 Vasopressin-regulated water reabsorption
    K08043  ADCY3; adenylate cyclase 3
  09156 Nervous system
   04724 Glutamatergic synapse
    K08043  ADCY3; adenylate cyclase 3
   04727 GABAergic synapse
    K08043  ADCY3; adenylate cyclase 3
   04725 Cholinergic synapse
    K08043  ADCY3; adenylate cyclase 3
   04723 Retrograde endocannabinoid signaling
    K08043  ADCY3; adenylate cyclase 3
  09157 Sensory system
   04740 Olfactory transduction
    K08043  ADCY3; adenylate cyclase 3
   04750 Inflammatory mediator regulation of TRP channels
    K08043  ADCY3; adenylate cyclase 3
  09149 Aging
   04211 Longevity regulating pathway
    K08043  ADCY3; adenylate cyclase 3
   04213 Longevity regulating pathway - multiple species
    K08043  ADCY3; adenylate cyclase 3
  09159 Environmental adaptation
   04713 Circadian entrainment
    K08043  ADCY3; adenylate cyclase 3
   04714 Thermogenesis
    K08043  ADCY3; adenylate cyclase 3
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K08043  ADCY3; adenylate cyclase 3
   05207 Chemical carcinogenesis - receptor activation
    K08043  ADCY3; adenylate cyclase 3
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K08043  ADCY3; adenylate cyclase 3
   05163 Human cytomegalovirus infection
    K08043  ADCY3; adenylate cyclase 3
  09171 Infectious disease: bacterial
   05110 Vibrio cholerae infection
    K08043  ADCY3; adenylate cyclase 3
  09165 Substance dependence
   05032 Morphine addiction
    K08043  ADCY3; adenylate cyclase 3
  09166 Cardiovascular disease
   05414 Dilated cardiomyopathy
    K08043  ADCY3; adenylate cyclase 3
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K08043  ADCY3; adenylate cyclase 3
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K08043  ADCY3; adenylate cyclase 3
Enzymes [BR:ko01000]
 4. Lyases
  4.6  Phosphorus-oxygen lyases
   4.6.1  Phosphorus-oxygen lyases (only sub-subclass identified to date)
    4.6.1.1  adenylate cyclase
     K08043  ADCY3; adenylate cyclase 3
Other DBs
RN: R00089 R00434
GO: 0008294
Genes
HSA: 109(ADCY3)
PTR: 459070(ADCY3)
PPS: 100995134(ADCY3)
GGO: 101144031(ADCY3)
PON: 100431221(ADCY3)
NLE: 100586735(ADCY3)
MCC: 693523(ADCY3)
MCF: 101925741(ADCY3)
CSAB: 103220665(ADCY3)
CATY: 105578529(ADCY3)
RRO: 104658457(ADCY3)
RBB: 108543021(ADCY3)
TFN: 117062665(ADCY3)
CJC: 100415165(ADCY3)
SBQ: 101040601(ADCY3)
MMUR: 105884349(ADCY3)
MMU: 104111(Adcy3)
MCAL: 110306494(Adcy3)
MPAH: 110324646(Adcy3)
RNO: 64508(Adcy3)
MCOC: 116079663(Adcy3)
MUN: 110555185(Adcy3)
CGE: 100770498(Adcy3)
PLEU: 114697107(Adcy3)
NGI: 103746460(Adcy3)
HGL: 101713887(Adcy3)
CCAN: 109685686(Adcy3)
OCU: 100343958(ADCY3)
TUP: 102477532(ADCY3)
CFA: 482994(ADCY3)
VVP: 112908545(ADCY3)
VLG: 121491160(ADCY3)
AML: 100471164(ADCY3)
UMR: 103671685(ADCY3)
UAH: 113270586(ADCY3)
ORO: 101368682(ADCY3)
ELK: 111154044
MPUF: 101671296(ADCY3)
EJU: 114205853(ADCY3)
FCA: 101088157(ADCY3)
PPAD: 109267527(ADCY3)
AJU: 106989109(ADCY3)
HHV: 120235801(ADCY3)
BTA: 535603(ADCY3)
BOM: 102282732(ADCY3)
BIU: 109566330(ADCY3)
BBUB: 102407976(ADCY3)
CHX: 102169019(ADCY3)
OAS: 101108203(ADCY3)
ODA: 120851596(ADCY3)
SSC: 100514402(ADCY3)
CFR: 102512950(ADCY3)
CDK: 105100030(ADCY3)
BACU: 103020845(ADCY3)
LVE: 103076182(ADCY3)
OOR: 101283651(ADCY3)
DLE: 111175000(ADCY3)
PCAD: 102989136(ADCY3)
ECB: 100055961(ADCY3)
EPZ: 103547823(ADCY3)
EAI: 106841140(ADCY3)
MYB: 102261014(ADCY3)
MYD: 102757252(ADCY3)
MMYO: 118669221(ADCY3)
MNA: 107534062(ADCY3)
HAI: 109385186(ADCY3)
DRO: 112297750(ADCY3)
SHON: 119001392(ADCY3)
AJM: 119050413(ADCY3)
MMF: 118630645(ADCY3)
PALE: 102886232(ADCY3)
RAY: 107498506(ADCY3)
MJV: 108397345(ADCY3)
LAV: 100674724(ADCY3)
TMU: 101349290
MDO: 100025332(ADCY3)
SHR: 100925657(ADCY3)
PCW: 110206523(ADCY3)
OAA: 100085901(ADCY3)
GGA: 422013(ADCY3)
PCOC: 116235620(ADCY3)
MGP: 100538467(ADCY3)
CJO: 107312346(ADCY3)
NMEL: 110395965(ADCY3)
APLA: 101791112(ADCY3)
PMOA: 120504513(ADCY3)
FPG: 101921567(ADCY3)
FCH: 102047195(ADCY3)
CLV: 102092425(ADCY3)
EGZ: 104132021(ADCY3)
NNI: 104014763(ADCY3)
ACUN: 113478856(ADCY3)
ASN: 102374249(ADCY3)
AMJ: 102566746(ADCY3)
CPOO: 109311539(ADCY3)
PSS: 102463305(ADCY3)
CMY: 102941584(ADCY3)
CPIC: 101948171(ADCY3)
TST: 117875434(ADCY3)
CABI: 116830876(ADCY3)
ACS: 100558229(adcy3)
PVT: 110089954(ADCY3)
PMUR: 107284867(ADCY3)
TSR: 106555200(ADCY3)
PGUT: 117667701(ADCY3)
PMUA: 114594931
ZVI: 118082958(ADCY3)
GJA: 107124706(ADCY3)
XLA: 108717252(adcy3.L) 108718304
XTR: 100038110(dnajc27)
NPR: 108795542(ADCY3)
DRE: 571825(adcy3a)
SGH: 107593287 107598935(adcy3)
IPU: 108271861(adcy3)
PHYP: 113526734(adcy3)
AMEX: 103027936(adcy3) 103034748
EEE: 113583134(adcy3)
TRU: 101066423(adcy3)
LCO: 104938398
NCC: 104945720
ELY: 117264741(adcy3a)
PLEP: 121945854(adcy3a) 121955311
SLUC: 116066597
GAT: 120807768 120810053(adcy3a)
MSAM: 119896893(adcy3a)
MZE: 101468640
ONL: 100710007
OAU: 116316197(adcy3a)
OLA: 101167167 105355856(adcy3)
XMA: 102219355(adcy3)
XCO: 114152719(adcy3)
XHE: 116717093(adcy3)
PRET: 103478767(adcy3)
NFU: 107378974(adcy3)
KMR: 108247740(adcy3a)
ALIM: 106530667
CSEM: 103388741(adcy3)
POV: 109632037(adcy3)
LCF: 108886083
SDU: 111227842
SLAL: 111664165
XGL: 120783866(adcy3a)
HCQ: 109521893(adcy3)
BPEC: 110159121(adcy3)
MALB: 109952263
SALP: 111972593 112069658(adcy3)
ELS: 105005964(adcy3)
SFM: 108929094(adcy3)
PKI: 111851542
LOC: 102683703(adcy3)
PSPA: 121316002(adcy3a)
ARUT: 117403044(adcy3a)
RTP: 109935189(adcy3)
BFO: 118404575
SPU: 582454
APLC: 110978247
DME: Dmel_CG1506(Ac3)
DER: 6548790
DSE: 6619304
DSI: Dsimw501_GD29214(Dsim_GD29214)
DAN: 6498294
DSR: 110185021
DPE: 6593540
DMN: 108163161
DWI: 6644450
DAZ: 108610471
DNV: 108658095
DHE: 111592509
DVI: 6628564
MDE: 101889515
LCQ: 111674541
ACOZ: 120955699
AARA: 120900035
AAG: 5571858
AALB: 115265620
CPII: 120422382
AME: 408363(Ac3)
BIM: 100743487
BTER: 100651573
CCAL: 108626049
OBB: 114872430
MGEN: 117225471
NMEA: 116434955
SOC: 105201589
MPHA: 105830745
AEC: 105143828
ACEP: 105620050
PBAR: 105427823
VEM: 105567376
HST: 105189653
DQU: 106743434
CFO: 105258159
FEX: 115245547
LHU: 105678451
PGC: 109856042
OBO: 105275628
PCF: 106784577
NVI: 100122644
CSOL: 105368022
MDL: 103570576
TCA: 657568
DPA: 109535556
ATD: 109599040
AGB: 111692202
NVL: 108559187
APLN: 108740017
PPYR: 116170321
OTU: 111419645
BMOR: 105842081
MSEX: 115441032
PPOT: 106099456
PXU: 106127520
ZCE: 119834210
PXY: 105387232
API: 100163190
DNX: 107161386
AGS: 114126436
RMD: 113555842
BTAB: 109035248
CLEC: 106670646
NLU: 111048874
ZNE: 110830923
CSEC: 117282028
FCD: 110846307
DSV: 119449210
RSAN: 119384145
RMP: 119169944
VDE: 111252385
VJA: 111263764
TUT: 107366670
DPTE: 113791730
CSCU: 111621814
PTEP: 107455365
SDM: 118187632
BGT: 106067539
GAE: 121388074
NVE: 5514741
ATEN: 116286473
 » show all
Reference
PMID:2255909
  Authors
Bakalyar HA, Reed RR
  Title
Identification of a specialized adenylyl cyclase that may mediate odorant detection.
  Journal
Science 250:1403-6 (1990)
DOI:10.1126/science.2255909
  Sequence
[rno:64508]
LinkDB

KEGG   ORTHOLOGY: K08044
Entry
K08044                      KO                                     

Name
ADCY4
Definition
adenylate cyclase 4 [EC:4.6.1.1]
Pathway
ko00230  Purine metabolism
ko01100  Metabolic pathways
ko01522  Endocrine resistance
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04062  Chemokine signaling pathway
ko04072  Phospholipase D signaling pathway
ko04114  Oocyte meiosis
ko04211  Longevity regulating pathway
ko04213  Longevity regulating pathway - multiple species
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04371  Apelin signaling pathway
ko04540  Gap junction
ko04611  Platelet activation
ko04713  Circadian entrainment
ko04714  Thermogenesis
ko04723  Retrograde endocannabinoid signaling
ko04724  Glutamatergic synapse
ko04725  Cholinergic synapse
ko04727  GABAergic synapse
ko04742  Taste transduction
ko04750  Inflammatory mediator regulation of TRP channels
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04913  Ovarian steroidogenesis
ko04914  Progesterone-mediated oocyte maturation
ko04915  Estrogen signaling pathway
ko04916  Melanogenesis
ko04918  Thyroid hormone synthesis
ko04921  Oxytocin signaling pathway
ko04923  Regulation of lipolysis in adipocytes
ko04925  Aldosterone synthesis and secretion
ko04926  Relaxin signaling pathway
ko04927  Cortisol synthesis and secretion
ko04928  Parathyroid hormone synthesis, secretion and action
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko04970  Salivary secretion
ko04971  Gastric acid secretion
ko04972  Pancreatic secretion
ko04976  Bile secretion
ko05032  Morphine addiction
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05200  Pathways in cancer
ko05207  Chemical carcinogenesis - receptor activation
ko05414  Dilated cardiomyopathy
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09104 Nucleotide metabolism
   00230 Purine metabolism
    K08044  ADCY4; adenylate cyclase 4
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K08044  ADCY4; adenylate cyclase 4
   04371 Apelin signaling pathway
    K08044  ADCY4; adenylate cyclase 4
   04020 Calcium signaling pathway
    K08044  ADCY4; adenylate cyclase 4
   04072 Phospholipase D signaling pathway
    K08044  ADCY4; adenylate cyclase 4
   04024 cAMP signaling pathway
    K08044  ADCY4; adenylate cyclase 4
   04022 cGMP-PKG signaling pathway
    K08044  ADCY4; adenylate cyclase 4
 09140 Cellular Processes
  09143 Cell growth and death
   04114 Oocyte meiosis
    K08044  ADCY4; adenylate cyclase 4
  09144 Cellular community - eukaryotes
   04540 Gap junction
    K08044  ADCY4; adenylate cyclase 4
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    K08044  ADCY4; adenylate cyclase 4
   04062 Chemokine signaling pathway
    K08044  ADCY4; adenylate cyclase 4
  09152 Endocrine system
   04911 Insulin secretion
    K08044  ADCY4; adenylate cyclase 4
   04923 Regulation of lipolysis in adipocytes
    K08044  ADCY4; adenylate cyclase 4
   04912 GnRH signaling pathway
    K08044  ADCY4; adenylate cyclase 4
   04913 Ovarian steroidogenesis
    K08044  ADCY4; adenylate cyclase 4
   04915 Estrogen signaling pathway
    K08044  ADCY4; adenylate cyclase 4
   04914 Progesterone-mediated oocyte maturation
    K08044  ADCY4; adenylate cyclase 4
   04921 Oxytocin signaling pathway
    K08044  ADCY4; adenylate cyclase 4
   04926 Relaxin signaling pathway
    K08044  ADCY4; adenylate cyclase 4
   04935 Growth hormone synthesis, secretion and action
    K08044  ADCY4; adenylate cyclase 4
   04918 Thyroid hormone synthesis
    K08044  ADCY4; adenylate cyclase 4
   04928 Parathyroid hormone synthesis, secretion and action
    K08044  ADCY4; adenylate cyclase 4
   04916 Melanogenesis
    K08044  ADCY4; adenylate cyclase 4
   04925 Aldosterone synthesis and secretion
    K08044  ADCY4; adenylate cyclase 4
   04927 Cortisol synthesis and secretion
    K08044  ADCY4; adenylate cyclase 4
  09153 Circulatory system
   04261 Adrenergic signaling in cardiomyocytes
    K08044  ADCY4; adenylate cyclase 4
   04270 Vascular smooth muscle contraction
    K08044  ADCY4; adenylate cyclase 4
  09154 Digestive system
   04970 Salivary secretion
    K08044  ADCY4; adenylate cyclase 4
   04971 Gastric acid secretion
    K08044  ADCY4; adenylate cyclase 4
   04972 Pancreatic secretion
    K08044  ADCY4; adenylate cyclase 4
   04976 Bile secretion
    K08044  ADCY4; adenylate cyclase 4
  09156 Nervous system
   04724 Glutamatergic synapse
    K08044  ADCY4; adenylate cyclase 4
   04727 GABAergic synapse
    K08044  ADCY4; adenylate cyclase 4
   04725 Cholinergic synapse
    K08044  ADCY4; adenylate cyclase 4
   04723 Retrograde endocannabinoid signaling
    K08044  ADCY4; adenylate cyclase 4
  09157 Sensory system
   04742 Taste transduction
    K08044  ADCY4; adenylate cyclase 4
   04750 Inflammatory mediator regulation of TRP channels
    K08044  ADCY4; adenylate cyclase 4
  09149 Aging
   04211 Longevity regulating pathway
    K08044  ADCY4; adenylate cyclase 4
   04213 Longevity regulating pathway - multiple species
    K08044  ADCY4; adenylate cyclase 4
  09159 Environmental adaptation
   04713 Circadian entrainment
    K08044  ADCY4; adenylate cyclase 4
   04714 Thermogenesis
    K08044  ADCY4; adenylate cyclase 4
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K08044  ADCY4; adenylate cyclase 4
   05207 Chemical carcinogenesis - receptor activation
    K08044  ADCY4; adenylate cyclase 4
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K08044  ADCY4; adenylate cyclase 4
   05163 Human cytomegalovirus infection
    K08044  ADCY4; adenylate cyclase 4
  09165 Substance dependence
   05032 Morphine addiction
    K08044  ADCY4; adenylate cyclase 4
  09166 Cardiovascular disease
   05414 Dilated cardiomyopathy
    K08044  ADCY4; adenylate cyclase 4
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K08044  ADCY4; adenylate cyclase 4
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K08044  ADCY4; adenylate cyclase 4
Enzymes [BR:ko01000]
 4. Lyases
  4.6  Phosphorus-oxygen lyases
   4.6.1  Phosphorus-oxygen lyases (only sub-subclass identified to date)
    4.6.1.1  adenylate cyclase
     K08044  ADCY4; adenylate cyclase 4
Other DBs
RN: R00089 R00434
GO: 0004016
Genes
HSA: 196883(ADCY4)
PTR: 452819(ADCY4)
PPS: 100978200(ADCY4)
GGO: 101125890(ADCY4)
PON: 100460806(ADCY4)
NLE: 100603282(ADCY4)
MCC: 714684(ADCY4)
MCF: 102123837(ADCY4)
CSAB: 103228726(ADCY4)
CATY: 105600225(ADCY4)
RRO: 104662674(ADCY4)
RBB: 108540946(ADCY4)
TFN: 117069900(ADCY4)
CJC: 100415141(ADCY4)
SBQ: 101044688(ADCY4)
MMUR: 105866617(ADCY4)
MMU: 104110(Adcy4)
MCAL: 110309267(Adcy4)
MPAH: 110325439(Adcy4)
RNO: 54223(Adcy4)
MCOC: 116084111(Adcy4)
MUN: 110556521(Adcy4)
CGE: 100768998(Adcy4)
PLEU: 114708701(Adcy4)
NGI: 103739411(Adcy4)
HGL: 101719464(Adcy4)
CCAN: 109685852(Adcy4)
OCU: 100346742(ADCY4)
TUP: 102490273(ADCY4)
CFA: 480271(ADCY4)
VVP: 112926558(ADCY4)
VLG: 121493259(ADCY4)
AML: 100471940(ADCY4)
UMR: 103679331(ADCY4)
UAH: 113246056(ADCY4)
ORO: 101374313(ADCY4)
ELK: 111162403
MPUF: 101676211(ADCY4)
EJU: 114217911(ADCY4)
FCA: 101097735(ADCY4)
PTG: 102965866(ADCY4)
PPAD: 109254969(ADCY4)
AJU: 106987869(ADCY4)
HHV: 120247005(ADCY4)
BTA: 788151(ADCY4)
BOM: 102286168(ADCY4)
BIU: 109564199(ADCY4)
BBUB: 102408103(ADCY4)
CHX: 102185469(ADCY4)
OAS: 101119139(ADCY4)
ODA: 120853482(ADCY4)
SSC: 100152067(ADCY4)
CFR: 102524031(ADCY4)
CDK: 105102432(ADCY4)
BACU: 103005549(ADCY4)
LVE: 103075499(ADCY4)
OOR: 101289858(ADCY4)
DLE: 111164225(ADCY4)
PCAD: 102985820(ADCY4)
ECB: 100054305(ADCY4)
EPZ: 103561050(ADCY4)
EAI: 106848607(ADCY4)
MYB: 102247996(ADCY4)
MYD: 102762536(ADCY4)
MMYO: 118678616(ADCY4)
MNA: 107531740(ADCY4)
HAI: 109393593(ADCY4)
DRO: 112300586(ADCY4)
SHON: 118980863(ADCY4)
AJM: 119037286(ADCY4)
MMF: 118631458(ADCY4)
PALE: 102890575(ADCY4)
RAY: 107498014(ADCY4)
MJV: 108410207(ADCY4)
LAV: 100675525(ADCY4)
TMU: 101350438
MDO: 100030872(ADCY4)
SHR: 100920243(ADCY4)
PCW: 110197384(ADCY4)
OAA: 103168714(ADCY4)
ASN: 102385636(ADCY4)
AMJ: 102558956(ADCY4)
PSS: 102451515
CMY: 102946725(ADCY4)
CPIC: 101936524(ADCY4)
TST: 117886223
CABI: 116839023(ADCY4)
ACS: 100562762(adcy4)
PVT: 110091692(ADCY4)
PBI: 103055695(ADCY4)
PMUR: 107286594(ADCY4)
TSR: 106549385(ADCY4)
PGUT: 117662171(ADCY4)
PMUA: 114581737(ADCY4)
ZVI: 118078718(ADCY4)
GJA: 107111738(ADCY4)
XLA: 108707036 108715027(adcy4.L)
XTR: 100497212(adcy4)
NPR: 108788450(ADCY4)
SGH: 107572836
CCAR: 109102764
IPU: 108260803
PHYP: 113544317
AMEX: 103031621
EEE: 113591496
KMR: 108248619
ALIM: 106527078
CSEM: 103384541
LCF: 108890756
HCQ: 109516520
BPEC: 110158296
SASA: 106608969
OTW: 112215078
OMY: 110500394
SALP: 111952465
ELS: 105030097
PKI: 111856451
 » show all
Reference
  Authors
Ludwig MG, Seuwen K
  Title
Characterization of the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms.
  Journal
J Recept Signal Transduct Res 22:79-110 (2002)
DOI:10.1081/RRS-120014589
  Sequence
[hsa:196883]
LinkDB

KEGG   ORTHOLOGY: K08045
Entry
K08045                      KO                                     

Name
ADCY5
Definition
adenylate cyclase 5 [EC:4.6.1.1]
Pathway
ko00230  Purine metabolism
ko01100  Metabolic pathways
ko01522  Endocrine resistance
ko04015  Rap1 signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04062  Chemokine signaling pathway
ko04072  Phospholipase D signaling pathway
ko04114  Oocyte meiosis
ko04211  Longevity regulating pathway
ko04213  Longevity regulating pathway - multiple species
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04371  Apelin signaling pathway
ko04540  Gap junction
ko04611  Platelet activation
ko04713  Circadian entrainment
ko04714  Thermogenesis
ko04723  Retrograde endocannabinoid signaling
ko04724  Glutamatergic synapse
ko04725  Cholinergic synapse
ko04726  Serotonergic synapse
ko04727  GABAergic synapse
ko04728  Dopaminergic synapse
ko04750  Inflammatory mediator regulation of TRP channels
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04913  Ovarian steroidogenesis
ko04914  Progesterone-mediated oocyte maturation
ko04915  Estrogen signaling pathway
ko04916  Melanogenesis
ko04918  Thyroid hormone synthesis
ko04921  Oxytocin signaling pathway
ko04923  Regulation of lipolysis in adipocytes
ko04924  Renin secretion
ko04925  Aldosterone synthesis and secretion
ko04926  Relaxin signaling pathway
ko04927  Cortisol synthesis and secretion
ko04928  Parathyroid hormone synthesis, secretion and action
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko04970  Salivary secretion
ko04971  Gastric acid secretion
ko04972  Pancreatic secretion
ko04976  Bile secretion
ko05012  Parkinson disease
ko05030  Cocaine addiction
ko05031  Amphetamine addiction
ko05032  Morphine addiction
ko05034  Alcoholism
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05200  Pathways in cancer
ko05207  Chemical carcinogenesis - receptor activation
ko05414  Dilated cardiomyopathy
Disease
H02389  Familial dyskinesia with facial myokymia
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09104 Nucleotide metabolism
   00230 Purine metabolism
    K08045  ADCY5; adenylate cyclase 5
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K08045  ADCY5; adenylate cyclase 5
   04371 Apelin signaling pathway
    K08045  ADCY5; adenylate cyclase 5
   04072 Phospholipase D signaling pathway
    K08045  ADCY5; adenylate cyclase 5
   04024 cAMP signaling pathway
    K08045  ADCY5; adenylate cyclase 5
   04022 cGMP-PKG signaling pathway
    K08045  ADCY5; adenylate cyclase 5
 09140 Cellular Processes
  09143 Cell growth and death
   04114 Oocyte meiosis
    K08045  ADCY5; adenylate cyclase 5
  09144 Cellular community - eukaryotes
   04540 Gap junction
    K08045  ADCY5; adenylate cyclase 5
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    K08045  ADCY5; adenylate cyclase 5
   04062 Chemokine signaling pathway
    K08045  ADCY5; adenylate cyclase 5
  09152 Endocrine system
   04911 Insulin secretion
    K08045  ADCY5; adenylate cyclase 5
   04923 Regulation of lipolysis in adipocytes
    K08045  ADCY5; adenylate cyclase 5
   04912 GnRH signaling pathway
    K08045  ADCY5; adenylate cyclase 5
   04913 Ovarian steroidogenesis
    K08045  ADCY5; adenylate cyclase 5
   04915 Estrogen signaling pathway
    K08045  ADCY5; adenylate cyclase 5
   04914 Progesterone-mediated oocyte maturation
    K08045  ADCY5; adenylate cyclase 5
   04921 Oxytocin signaling pathway
    K08045  ADCY5; adenylate cyclase 5
   04926 Relaxin signaling pathway
    K08045  ADCY5; adenylate cyclase 5
   04935 Growth hormone synthesis, secretion and action
    K08045  ADCY5; adenylate cyclase 5
   04918 Thyroid hormone synthesis
    K08045  ADCY5; adenylate cyclase 5
   04928 Parathyroid hormone synthesis, secretion and action
    K08045  ADCY5; adenylate cyclase 5
   04916 Melanogenesis
    K08045  ADCY5; adenylate cyclase 5
   04924 Renin secretion
    K08045  ADCY5; adenylate cyclase 5
   04925 Aldosterone synthesis and secretion
    K08045  ADCY5; adenylate cyclase 5
   04927 Cortisol synthesis and secretion
    K08045  ADCY5; adenylate cyclase 5
  09153 Circulatory system
   04261 Adrenergic signaling in cardiomyocytes
    K08045  ADCY5; adenylate cyclase 5
   04270 Vascular smooth muscle contraction
    K08045  ADCY5; adenylate cyclase 5
  09154 Digestive system
   04970 Salivary secretion
    K08045  ADCY5; adenylate cyclase 5
   04971 Gastric acid secretion
    K08045  ADCY5; adenylate cyclase 5
   04972 Pancreatic secretion
    K08045  ADCY5; adenylate cyclase 5
   04976 Bile secretion
    K08045  ADCY5; adenylate cyclase 5
  09156 Nervous system
   04724 Glutamatergic synapse
    K08045  ADCY5; adenylate cyclase 5
   04727 GABAergic synapse
    K08045  ADCY5; adenylate cyclase 5
   04725 Cholinergic synapse
    K08045  ADCY5; adenylate cyclase 5
   04728 Dopaminergic synapse
    K08045  ADCY5; adenylate cyclase 5
   04726 Serotonergic synapse
    K08045  ADCY5; adenylate cyclase 5
   04723 Retrograde endocannabinoid signaling
    K08045  ADCY5; adenylate cyclase 5
  09157 Sensory system
   04750 Inflammatory mediator regulation of TRP channels
    K08045  ADCY5; adenylate cyclase 5
  09149 Aging
   04211 Longevity regulating pathway
    K08045  ADCY5; adenylate cyclase 5
   04213 Longevity regulating pathway - multiple species
    K08045  ADCY5; adenylate cyclase 5
  09159 Environmental adaptation
   04713 Circadian entrainment
    K08045  ADCY5; adenylate cyclase 5
   04714 Thermogenesis
    K08045  ADCY5; adenylate cyclase 5
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K08045  ADCY5; adenylate cyclase 5
   05207 Chemical carcinogenesis - receptor activation
    K08045  ADCY5; adenylate cyclase 5
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K08045  ADCY5; adenylate cyclase 5
   05163 Human cytomegalovirus infection
    K08045  ADCY5; adenylate cyclase 5
  09164 Neurodegenerative disease
   05012 Parkinson disease
    K08045  ADCY5; adenylate cyclase 5
  09165 Substance dependence
   05030 Cocaine addiction
    K08045  ADCY5; adenylate cyclase 5
   05031 Amphetamine addiction
    K08045  ADCY5; adenylate cyclase 5
   05032 Morphine addiction
    K08045  ADCY5; adenylate cyclase 5
   05034 Alcoholism
    K08045  ADCY5; adenylate cyclase 5
  09166 Cardiovascular disease
   05414 Dilated cardiomyopathy
    K08045  ADCY5; adenylate cyclase 5
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K08045  ADCY5; adenylate cyclase 5
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K08045  ADCY5; adenylate cyclase 5
Enzymes [BR:ko01000]
 4. Lyases
  4.6  Phosphorus-oxygen lyases
   4.6.1  Phosphorus-oxygen lyases (only sub-subclass identified to date)
    4.6.1.1  adenylate cyclase
     K08045  ADCY5; adenylate cyclase 5
Other DBs
RN: R00089 R00434
GO: 0004016
Genes
HSA: 111(ADCY5)
PTR: 470905(ADCY5)
PPS: 100989177(ADCY5)
GGO: 101150181(ADCY5)
PON: 100454138(ADCY5)
NLE: 100580455(ADCY5)
MCC: 715897(ADCY5)
MCF: 102135142(ADCY5)
CSAB: 103228169(ADCY5)
CATY: 105589787(ADCY5)
RRO: 104668142(ADCY5)
RBB: 108517430(ADCY5)
TFN: 117083400(ADCY5)
CJC: 100412782(ADCY5)
SBQ: 101049747(ADCY5)
MMUR: 105879870(ADCY5)
MMU: 224129(Adcy5)
MCAL: 110311373(Adcy5)
MPAH: 110329393(Adcy5)
RNO: 64532(Adcy5)
MCOC: 116085856(Adcy5)
MUN: 110547229(Adcy5)
CGE: 100765958(Adcy5)
PLEU: 114704841(Adcy5)
NGI: 103741989(Adcy5)
HGL: 101702436(Adcy5)
CCAN: 109701078(Adcy5)
OCU: 100009315(ADCY5)
TUP: 102490639(ADCY5)
CFA: 403859(ADCY5)
VVP: 112913504(ADCY5)
VLG: 121501047(ADCY5)
AML: 100482519(ADCY5)
UMR: 103678826(ADCY5)
UAH: 113252326(ADCY5)
ORO: 101380824(ADCY5)
ELK: 111155044
MPUF: 101673819(ADCY5)
EJU: 114199416(ADCY5)
FCA: 101100749(ADCY5)
PTG: 102969833(ADCY5)
PPAD: 109266493(ADCY5)
AJU: 106984082(ADCY5)
HHV: 120237362(ADCY5)
BTA: 505740(ADCY5)
BOM: 102276460(ADCY5)
BIU: 109555842(ADCY5)
BBUB: 102405387(ADCY5)
CHX: 102189798(ADCY5)
OAS: 105602258(ADCY5)
ODA: 120870754(ADCY5)
SSC: 100155970(ADCY5)
CFR: 102503785(ADCY5)
CDK: 105090284(ADCY5)
BACU: 103006764(ADCY5)
LVE: 103091169(ADCY5)
OOR: 101283178(ADCY5)
DLE: 111171650(ADCY5)
PCAD: 102983319(ADCY5)
ECB: 100070498(ADCY5)
EPZ: 103563830(ADCY5)
EAI: 106823728(ADCY5)
MYB: 102257731(ADCY5)
MYD: 102760678(ADCY5)
MMYO: 118676734(ADCY5)
MNA: 107527242(ADCY5)
HAI: 109387200(ADCY5)
DRO: 112320488(ADCY5)
SHON: 118990736(ADCY5)
AJM: 119039523(ADCY5)
MMF: 118617134(ADCY5)
PALE: 102897495(ADCY5)
RAY: 107518038(ADCY5)
MJV: 108396721(ADCY5)
LAV: 100670244(ADCY5)
TMU: 101346041
MDO: 100019274(ADCY5)
PCW: 110208122(ADCY5)
OAA: 114811232(ADCY5)
GGA: 395340(ADCY5)
PCOC: 116227376(ADCY5)
MGP: 100547372(ADCY5)
CJO: 107316827(ADCY5)
NMEL: 110399200(ADCY5)
APLA: 101794067(ADCY5)
ACYG: 106029894(ADCY5)
TGU: 100220777(ADCY5)
LSR: 110468293(ADCY5)
SCAN: 103814312(ADCY5)
PMOA: 120497513(ADCY5)
GFR: 102031760(ADCY5)
FAB: 101807084(ADCY5)
PHI: 102107286(ADCY5)
PMAJ: 107207500(ADCY5)
CCAE: 111932249(ADCY5)
CCW: 104694019(ADCY5)
ETL: 114058103(ADCY5)
FPG: 101922323(ADCY5)
FCH: 102049855(ADCY5)
CLV: 102085466(ADCY5)
EGZ: 104128107(ADCY5)
NNI: 104018815(ADCY5)
ACUN: 113482358(ADCY5)
PADL: 103919638(ADCY5)
AAM: 106499045(ADCY5)
ASN: 102387635
AMJ: 102562224(ADCY5)
CPOO: 109322645(ADCY5)
GGN: 109301418(ADCY5)
PSS: 102461993(ADCY5)
CMY: 102937309(ADCY5)
CPIC: 101950146(ADCY5)
TST: 117885025(ADCY5)
CABI: 116834742(ADCY5)
ACS: 100558125(adcy5)
PVT: 110083012(ADCY5)
PBI: 103060584(ADCY5)
PMUR: 107285748
TSR: 106553086(ADCY5)
PGUT: 117668834(ADCY5)
PMUA: 114603889(ADCY5)
ZVI: 118091724(ADCY5)
GJA: 107113906
XLA: 108701255 108702898(adcy5.S)
XTR: 100490464(adcy5)
NPR: 108801019
DRE: 562619(adcy5)
IPU: 108266230(adcy5)
PHYP: 113525981(adcy5)
AMEX: 103026414(adcy5)
EEE: 113567484(adcy5)
TRU: 101070040(adcy5)
LCO: 104918228(adcy5)
ELY: 117251312(adcy5)
PLEP: 121948834(adcy5)
SLUC: 116067017(adcy5)
GAT: 120834348(adcy5)
MSAM: 119904436(adcy5)
MZE: 101480556(adcy5)
ONL: 100698700(adcy5)
OAU: 116314774(adcy5)
OLA: 101174709(adcy5)
OML: 112154945(adcy5)
XMA: 102229859(adcy5)
XCO: 114147875(adcy5)
XHE: 116722709(adcy5)
PRET: 103478500(adcy5)
CVG: 107101604(adcy5)
NFU: 107389655(adcy5)
KMR: 108238863(adcy5)
AOCE: 111573705(adcy5)
CSEM: 103391879(adcy5)
POV: 109637957
LCF: 108897108(adcy5)
SDU: 111218374(adcy5)
SLAL: 111657529(adcy5)
XGL: 120801527(adcy5)
HCQ: 109521852
BPEC: 110156638(adcy5)
MALB: 109974016(adcy5)
SASA: 106582348(adcy5) 106586396
OMY: 110501809 110520268(adcy5)
ELS: 105016121(adcy5)
PKI: 111851750(adcy5)
LOC: 102689480(adcy5)
LCM: 102353581(ADCY5)
BFO: 118425098
CIN: 778532
SCLV: 120337426
SPU: 582776
APLC: 110979349
SKO: 100376780
AME: 726514
BIM: 100747315
BTER: 100645307
CCAL: 108628661
OBB: 114879773
MGEN: 117220940
SOC: 105204551
MPHA: 105838640
AEC: 105154476
ACEP: 105621266
PBAR: 105430765
VEM: 105563054
HST: 105191454
DQU: 106750327
CFO: 105258714
LHU: 105679715
PGC: 109857578
OBO: 105275369
PCF: 106791020
MDL: 103580107
TCA: 659486
DPA: 109540307
ATD: 109594012
NVL: 108568296
BMOR: 101739615
BMAN: 114247436
PMAC: 106715905
PRAP: 111003341
ZCE: 119835849
HAW: 110379459
PXY: 105387103
API: 100160451
DNX: 107169163
RMD: 113549620
BTAB: 109042497
ZNE: 110830589
FCD: 110843276
DPX: DAPPUDRAFT_39757(Adcy1)
PVM: 113822760
EAF: 111714019
DSV: 119442339
RSAN: 119387173
VDE: 111245001
VJA: 111265391
CSCU: 111624573
PTEP: 107439050
SDM: 118188448
PCAN: 112563595
BGT: 106061562
GAE: 121381879
CRG: 105346394
MYI: 110463711
PMAX: 117343741
OBI: 106882760
LAK: 106171289
NVE: 5517880
EPA: 110245505
ADF: 107356750
AMIL: 114970122
PDAM: 113666552
SPIS: 111343062
DGT: 114520988
HMG: 100210301
 » show all
Reference
  Authors
Ludwig MG, Seuwen K
  Title
Characterization of the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms.
  Journal
J Recept Signal Transduct Res 22:79-110 (2002)
DOI:10.1081/RRS-120014589
  Sequence
[hsa:111]
Reference
  Authors
Ding Q, Gros R, Gray ID, Taussig R, Ferguson SS, Feldman RD
  Title
Raf kinase activation of adenylyl cyclases: isoform-selective regulation.
  Journal
Mol Pharmacol 66:921-8 (2004)
DOI:10.1124/mol.66.4.921
LinkDB

KEGG   ORTHOLOGY: K08046
Entry
K08046                      KO                                     

Name
ADCY6
Definition
adenylate cyclase 6 [EC:4.6.1.1]
Pathway
ko00230  Purine metabolism
ko01100  Metabolic pathways
ko01522  Endocrine resistance
ko04015  Rap1 signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04062  Chemokine signaling pathway
ko04072  Phospholipase D signaling pathway
ko04114  Oocyte meiosis
ko04211  Longevity regulating pathway
ko04213  Longevity regulating pathway - multiple species
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04371  Apelin signaling pathway
ko04540  Gap junction
ko04611  Platelet activation
ko04713  Circadian entrainment
ko04714  Thermogenesis
ko04723  Retrograde endocannabinoid signaling
ko04724  Glutamatergic synapse
ko04725  Cholinergic synapse
ko04727  GABAergic synapse
ko04742  Taste transduction
ko04750  Inflammatory mediator regulation of TRP channels
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04913  Ovarian steroidogenesis
ko04914  Progesterone-mediated oocyte maturation
ko04915  Estrogen signaling pathway
ko04916  Melanogenesis
ko04918  Thyroid hormone synthesis
ko04921  Oxytocin signaling pathway
ko04923  Regulation of lipolysis in adipocytes
ko04924  Renin secretion
ko04925  Aldosterone synthesis and secretion
ko04926  Relaxin signaling pathway
ko04927  Cortisol synthesis and secretion
ko04928  Parathyroid hormone synthesis, secretion and action
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko04961  Endocrine and other factor-regulated calcium reabsorption
ko04962  Vasopressin-regulated water reabsorption
ko04970  Salivary secretion
ko04971  Gastric acid secretion
ko04972  Pancreatic secretion
ko04976  Bile secretion
ko05032  Morphine addiction
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05200  Pathways in cancer
ko05207  Chemical carcinogenesis - receptor activation
ko05414  Dilated cardiomyopathy
Disease
H00865  Lethal congenital contractural syndrome
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09104 Nucleotide metabolism
   00230 Purine metabolism
    K08046  ADCY6; adenylate cyclase 6
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K08046  ADCY6; adenylate cyclase 6
   04371 Apelin signaling pathway
    K08046  ADCY6; adenylate cyclase 6
   04072 Phospholipase D signaling pathway
    K08046  ADCY6; adenylate cyclase 6
   04024 cAMP signaling pathway
    K08046  ADCY6; adenylate cyclase 6
   04022 cGMP-PKG signaling pathway
    K08046  ADCY6; adenylate cyclase 6
 09140 Cellular Processes
  09143 Cell growth and death
   04114 Oocyte meiosis
    K08046  ADCY6; adenylate cyclase 6
  09144 Cellular community - eukaryotes
   04540 Gap junction
    K08046  ADCY6; adenylate cyclase 6
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    K08046  ADCY6; adenylate cyclase 6
   04062 Chemokine signaling pathway
    K08046  ADCY6; adenylate cyclase 6
  09152 Endocrine system
   04911 Insulin secretion
    K08046  ADCY6; adenylate cyclase 6
   04923 Regulation of lipolysis in adipocytes
    K08046  ADCY6; adenylate cyclase 6
   04912 GnRH signaling pathway
    K08046  ADCY6; adenylate cyclase 6
   04913 Ovarian steroidogenesis
    K08046  ADCY6; adenylate cyclase 6
   04915 Estrogen signaling pathway
    K08046  ADCY6; adenylate cyclase 6
   04914 Progesterone-mediated oocyte maturation
    K08046  ADCY6; adenylate cyclase 6
   04921 Oxytocin signaling pathway
    K08046  ADCY6; adenylate cyclase 6
   04926 Relaxin signaling pathway
    K08046  ADCY6; adenylate cyclase 6
   04935 Growth hormone synthesis, secretion and action
    K08046  ADCY6; adenylate cyclase 6
   04918 Thyroid hormone synthesis
    K08046  ADCY6; adenylate cyclase 6
   04928 Parathyroid hormone synthesis, secretion and action
    K08046  ADCY6; adenylate cyclase 6
   04916 Melanogenesis
    K08046  ADCY6; adenylate cyclase 6
   04924 Renin secretion
    K08046  ADCY6; adenylate cyclase 6
   04925 Aldosterone synthesis and secretion
    K08046  ADCY6; adenylate cyclase 6
   04927 Cortisol synthesis and secretion
    K08046  ADCY6; adenylate cyclase 6
  09153 Circulatory system
   04261 Adrenergic signaling in cardiomyocytes
    K08046  ADCY6; adenylate cyclase 6
   04270 Vascular smooth muscle contraction
    K08046  ADCY6; adenylate cyclase 6
  09154 Digestive system
   04970 Salivary secretion
    K08046  ADCY6; adenylate cyclase 6
   04971 Gastric acid secretion
    K08046  ADCY6; adenylate cyclase 6
   04972 Pancreatic secretion
    K08046  ADCY6; adenylate cyclase 6
   04976 Bile secretion
    K08046  ADCY6; adenylate cyclase 6
  09155 Excretory system
   04962 Vasopressin-regulated water reabsorption
    K08046  ADCY6; adenylate cyclase 6
   04961 Endocrine and other factor-regulated calcium reabsorption
    K08046  ADCY6; adenylate cyclase 6
  09156 Nervous system
   04724 Glutamatergic synapse
    K08046  ADCY6; adenylate cyclase 6
   04727 GABAergic synapse
    K08046  ADCY6; adenylate cyclase 6
   04725 Cholinergic synapse
    K08046  ADCY6; adenylate cyclase 6
   04723 Retrograde endocannabinoid signaling
    K08046  ADCY6; adenylate cyclase 6
  09157 Sensory system
   04742 Taste transduction
    K08046  ADCY6; adenylate cyclase 6
   04750 Inflammatory mediator regulation of TRP channels
    K08046  ADCY6; adenylate cyclase 6
  09149 Aging
   04211 Longevity regulating pathway
    K08046  ADCY6; adenylate cyclase 6
   04213 Longevity regulating pathway - multiple species
    K08046  ADCY6; adenylate cyclase 6
  09159 Environmental adaptation
   04713 Circadian entrainment
    K08046  ADCY6; adenylate cyclase 6
   04714 Thermogenesis
    K08046  ADCY6; adenylate cyclase 6
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K08046  ADCY6; adenylate cyclase 6
   05207 Chemical carcinogenesis - receptor activation
    K08046  ADCY6; adenylate cyclase 6
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K08046  ADCY6; adenylate cyclase 6
   05163 Human cytomegalovirus infection
    K08046  ADCY6; adenylate cyclase 6
  09165 Substance dependence
   05032 Morphine addiction
    K08046  ADCY6; adenylate cyclase 6
  09166 Cardiovascular disease
   05414 Dilated cardiomyopathy
    K08046  ADCY6; adenylate cyclase 6
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K08046  ADCY6; adenylate cyclase 6
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K08046  ADCY6; adenylate cyclase 6
Enzymes [BR:ko01000]
 4. Lyases
  4.6  Phosphorus-oxygen lyases
   4.6.1  Phosphorus-oxygen lyases (only sub-subclass identified to date)
    4.6.1.1  adenylate cyclase
     K08046  ADCY6; adenylate cyclase 6
Other DBs
RN: R00089 R00434
GO: 0004016
Genes
HSA: 112(ADCY6)
PTR: 451866(ADCY6)
PPS: 100991116(ADCY6)
GGO: 101139873(ADCY6)
PON: 100438178(ADCY6)
NLE: 100589304(ADCY6)
MCC: 707978(ADCY6)
MCF: 102116122(ADCY6)
CSAB: 103238242(ADCY6)
CATY: 105580404(ADCY6)
RRO: 104654871(ADCY6)
RBB: 108543933(ADCY6)
TFN: 117090196(ADCY6)
CJC: 100406617(ADCY6)
SBQ: 101037803(ADCY6)
MMUR: 105867497(ADCY6)
MMU: 11512(Adcy6)
MCAL: 110310126(Adcy6)
MPAH: 110334500(Adcy6)
RNO: 25289(Adcy6)
MCOC: 116079067(Adcy6)
CGE: 100768368(Adcy6)
PLEU: 114708522(Adcy6)
NGI: 103750558(Adcy6)
HGL: 101698189(Adcy6)
CCAN: 109686365(Adcy6)
OCU: 100354934(ADCY6)
TUP: 102468478(ADCY6)
CFA: 477625(ADCY6)
VVP: 112921089(ADCY6)
VLG: 121479760(ADCY6)
AML: 100476922(ADCY6)
UMR: 103675618(ADCY6)
UAH: 113257671(ADCY6)
ORO: 101373816(ADCY6)
ELK: 111157825
MPUF: 101676713(ADCY6)
EJU: 114225777(ADCY6)
FCA: 101091211(ADCY6)
PTG: 102949044(ADCY6)
PPAD: 109249043(ADCY6)
AJU: 106969297(ADCY6)
HHV: 120223032(ADCY6)
BTA: 509936(ADCY6)
BOM: 102265325(ADCY6)
BIU: 109559159(ADCY6)
BBUB: 102407637(ADCY6)
CHX: 102169557(ADCY6)
OAS: 101105735(ADCY6)
SSC: 100522613(ADCY6)
CFR: 102519611(ADCY6)
CDK: 105103816(ADCY6)
BACU: 103014094(ADCY6)
LVE: 103075153(ADCY6)
OOR: 101273023(ADCY6)
DLE: 111174035(ADCY6)
PCAD: 102986152(ADCY6)
ECB: 100051295(ADCY6)
EPZ: 103563634(ADCY6)
EAI: 106836825(ADCY6)
MYB: 102248773(ADCY6)
MYD: 102766123(ADCY6)
MMYO: 118650262(ADCY6)
MNA: 107528232(ADCY6)
HAI: 109393238(ADCY6)
DRO: 112318673(ADCY6)
SHON: 118976509(ADCY6)
AJM: 119042160(ADCY6)
MMF: 118623920(ADCY6)
PALE: 102890588(ADCY6)
RAY: 107514224(ADCY6)
MJV: 108383520(ADCY6)
LAV: 100653532(ADCY6)
TMU: 101349243
SHR: 100932634(ADCY6)
PCW: 110201474(ADCY6)
OAA: 100081118(ADCY6)
GGA: 107050028
CJO: 107307087(ADCY6)
TGU: 100223723(ADCY6)
LSR: 110480398(ADCY6)
SCAN: 103824610(ADCY6)
PMOA: 120499475(ADCY6)
GFR: 102033025(ADCY6)
FAB: 101810909(ADCY6)
PHI: 102101002(ADCY6)
PMAJ: 107198603(ADCY6)
CCAE: 111940536(ADCY6)
ETL: 114071073
FPG: 101916278(ADCY6)
FCH: 102050328(ADCY6)
CLV: 102092552(ADCY6)
NNI: 104019883(ADCY6)
ASN: 102388125(ADCY6)
AMJ: 102573402(ADCY6)
CPOO: 109324447(ADCY6)
PSS: 102448834(ADCY6)
CMY: 102942183(ADCY6)
CPIC: 101948443(ADCY6)
TST: 117889271(ADCY6)
CABI: 116827794(ADCY6)
ACS: 100558069(adcy6)
PVT: 110074939(ADCY6)
PBI: 103050190(ADCY6)
PMUR: 107290979
TSR: 106539925
PGUT: 117662735(ADCY6)
PMUA: 114592965(ADCY6)
ZVI: 118077506(ADCY6)
GJA: 107120916(ADCY6)
XLA: 108708542(adcy6.L) 414728(adcy6.S)
XTR: 100493933(adcy6)
NPR: 108802250
DRE: 560807(adcy6b) 570652(adcy6a)
IPU: 108276068(ADCY6)
PHYP: 113530428(adcy6)
EEE: 113583096(adcy6) 113591158
LCO: 104919645(adcy6) 104933400
ELY: 117258192(adcy6b) 117258226
PLEP: 121946801
MZE: 101473262 101483853(adcy6)
ONL: 100702460 100704485(adcy6)
OAU: 116310917 116325822(adcy6b)
OLA: 101158108(adcy6) 101169035
XMA: 102232614(adcy6) 102235040
XHE: 116726440(adcy6) 116726867
PRET: 103467316 103467625(adcy6)
NFU: 107390847 107391215(adcy6)
CSEM: 103384589 103385410(adcy6)
LCF: 108876515 108900204(adcy6)
SLAL: 111670684 111671536(adcy6)
BPEC: 110164760(adcy6) 110164822
MALB: 109966043(adcy6) 109968886
SFM: 108918490(adcy6) 108939304
PKI: 111837572(adcy6)
LOC: 102693411(adcy6)
PSPA: 121309011(adcy6a)
LCM: 102366154(ADCY6)
NMEA: 116426288
CLEC: 106671898
NLU: 111044161
RMP: 119159572
ATEN: 116306816
 » show all
Reference
  Authors
Wicker R, Catalan AG, Cailleux A, Starenki D, Stengel D, Sarasin A, Suarez HG
  Title
Cloning and expression of human adenylyl cyclase type VI in normal thyroid tissues.
  Journal
Biochim Biophys Acta 1493:279-83 (2000)
DOI:10.1016/S0167-4781(00)00187-1
  Sequence
[hsa:112]
Reference
  Authors
Ding Q, Gros R, Gray ID, Taussig R, Ferguson SS, Feldman RD
  Title
Raf kinase activation of adenylyl cyclases: isoform-selective regulation.
  Journal
Mol Pharmacol 66:921-8 (2004)
DOI:10.1124/mol.66.4.921
LinkDB

KEGG   ORTHOLOGY: K08047
Entry
K08047                      KO                                     

Name
ADCY7
Definition
adenylate cyclase 7 [EC:4.6.1.1]
Pathway
ko00230  Purine metabolism
ko01100  Metabolic pathways
ko01522  Endocrine resistance
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04062  Chemokine signaling pathway
ko04072  Phospholipase D signaling pathway
ko04114  Oocyte meiosis
ko04211  Longevity regulating pathway
ko04213  Longevity regulating pathway - multiple species
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04371  Apelin signaling pathway
ko04540  Gap junction
ko04611  Platelet activation
ko04713  Circadian entrainment
ko04714  Thermogenesis
ko04723  Retrograde endocannabinoid signaling
ko04724  Glutamatergic synapse
ko04725  Cholinergic synapse
ko04727  GABAergic synapse
ko04750  Inflammatory mediator regulation of TRP channels
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04913  Ovarian steroidogenesis
ko04914  Progesterone-mediated oocyte maturation
ko04915  Estrogen signaling pathway
ko04916  Melanogenesis
ko04918  Thyroid hormone synthesis
ko04921  Oxytocin signaling pathway
ko04923  Regulation of lipolysis in adipocytes
ko04925  Aldosterone synthesis and secretion
ko04926  Relaxin signaling pathway
ko04927  Cortisol synthesis and secretion
ko04928  Parathyroid hormone synthesis, secretion and action
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko04970  Salivary secretion
ko04971  Gastric acid secretion
ko04972  Pancreatic secretion
ko04976  Bile secretion
ko05032  Morphine addiction
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05200  Pathways in cancer
ko05207  Chemical carcinogenesis - receptor activation
ko05414  Dilated cardiomyopathy
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09104 Nucleotide metabolism
   00230 Purine metabolism
    K08047  ADCY7; adenylate cyclase 7
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K08047  ADCY7; adenylate cyclase 7
   04371 Apelin signaling pathway
    K08047  ADCY7; adenylate cyclase 7
   04020 Calcium signaling pathway
    K08047  ADCY7; adenylate cyclase 7
   04072 Phospholipase D signaling pathway
    K08047  ADCY7; adenylate cyclase 7
   04024 cAMP signaling pathway
    K08047  ADCY7; adenylate cyclase 7
   04022 cGMP-PKG signaling pathway
    K08047  ADCY7; adenylate cyclase 7
 09140 Cellular Processes
  09143 Cell growth and death
   04114 Oocyte meiosis
    K08047  ADCY7; adenylate cyclase 7
  09144 Cellular community - eukaryotes
   04540 Gap junction
    K08047  ADCY7; adenylate cyclase 7
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    K08047  ADCY7; adenylate cyclase 7
   04062 Chemokine signaling pathway
    K08047  ADCY7; adenylate cyclase 7
  09152 Endocrine system
   04911 Insulin secretion
    K08047  ADCY7; adenylate cyclase 7
   04923 Regulation of lipolysis in adipocytes
    K08047  ADCY7; adenylate cyclase 7
   04912 GnRH signaling pathway
    K08047  ADCY7; adenylate cyclase 7
   04913 Ovarian steroidogenesis
    K08047  ADCY7; adenylate cyclase 7
   04915 Estrogen signaling pathway
    K08047  ADCY7; adenylate cyclase 7
   04914 Progesterone-mediated oocyte maturation
    K08047  ADCY7; adenylate cyclase 7
   04921 Oxytocin signaling pathway
    K08047  ADCY7; adenylate cyclase 7
   04926 Relaxin signaling pathway
    K08047  ADCY7; adenylate cyclase 7
   04935 Growth hormone synthesis, secretion and action
    K08047  ADCY7; adenylate cyclase 7
   04918 Thyroid hormone synthesis
    K08047  ADCY7; adenylate cyclase 7
   04928 Parathyroid hormone synthesis, secretion and action
    K08047  ADCY7; adenylate cyclase 7
   04916 Melanogenesis
    K08047  ADCY7; adenylate cyclase 7
   04925 Aldosterone synthesis and secretion
    K08047  ADCY7; adenylate cyclase 7
   04927 Cortisol synthesis and secretion
    K08047  ADCY7; adenylate cyclase 7
  09153 Circulatory system
   04261 Adrenergic signaling in cardiomyocytes
    K08047  ADCY7; adenylate cyclase 7
   04270 Vascular smooth muscle contraction
    K08047  ADCY7; adenylate cyclase 7
  09154 Digestive system
   04970 Salivary secretion
    K08047  ADCY7; adenylate cyclase 7
   04971 Gastric acid secretion
    K08047  ADCY7; adenylate cyclase 7
   04972 Pancreatic secretion
    K08047  ADCY7; adenylate cyclase 7
   04976 Bile secretion
    K08047  ADCY7; adenylate cyclase 7
  09156 Nervous system
   04724 Glutamatergic synapse
    K08047  ADCY7; adenylate cyclase 7
   04727 GABAergic synapse
    K08047  ADCY7; adenylate cyclase 7
   04725 Cholinergic synapse
    K08047  ADCY7; adenylate cyclase 7
   04723 Retrograde endocannabinoid signaling
    K08047  ADCY7; adenylate cyclase 7
  09157 Sensory system
   04750 Inflammatory mediator regulation of TRP channels
    K08047  ADCY7; adenylate cyclase 7
  09149 Aging
   04211 Longevity regulating pathway
    K08047  ADCY7; adenylate cyclase 7
   04213 Longevity regulating pathway - multiple species
    K08047  ADCY7; adenylate cyclase 7
  09159 Environmental adaptation
   04713 Circadian entrainment
    K08047  ADCY7; adenylate cyclase 7
   04714 Thermogenesis
    K08047  ADCY7; adenylate cyclase 7
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K08047  ADCY7; adenylate cyclase 7
   05207 Chemical carcinogenesis - receptor activation
    K08047  ADCY7; adenylate cyclase 7
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K08047  ADCY7; adenylate cyclase 7
   05163 Human cytomegalovirus infection
    K08047  ADCY7; adenylate cyclase 7
  09165 Substance dependence
   05032 Morphine addiction
    K08047  ADCY7; adenylate cyclase 7
  09166 Cardiovascular disease
   05414 Dilated cardiomyopathy
    K08047  ADCY7; adenylate cyclase 7
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K08047  ADCY7; adenylate cyclase 7
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K08047  ADCY7; adenylate cyclase 7
Enzymes [BR:ko01000]
 4. Lyases
  4.6  Phosphorus-oxygen lyases
   4.6.1  Phosphorus-oxygen lyases (only sub-subclass identified to date)
    4.6.1.1  adenylate cyclase
     K08047  ADCY7; adenylate cyclase 7
Other DBs
RN: R00089 R00434
GO: 0004016
Genes
HSA: 113(ADCY7)
PTR: 473278(ADCY7)
PPS: 100984225(ADCY7)
GGO: 101126268(ADCY7)
PON: 100436577(ADCY7)
NLE: 100587036(ADCY7)
MCC: 694730(ADCY7)
MCF: 102125718(ADCY7)
CSAB: 103232667(ADCY7)
CATY: 105588901(ADCY7)
RRO: 104672569(ADCY7)
RBB: 108522948(ADCY7)
TFN: 117087765(ADCY7)
CJC: 100404620(ADCY7)
SBQ: 101032672(ADCY7)
MMUR: 105884745(ADCY7)
MMU: 11513(Adcy7)
MCAL: 110299719(Adcy7)
MPAH: 110337453(Adcy7)
RNO: 84420(Adcy7)
MCOC: 116069817(Adcy7)
MUN: 110560723(Adcy7)
CGE: 100756132(Adcy7)
PLEU: 114708501(Adcy7)
NGI: 103730120(Adcy7)
HGL: 101712483(Adcy7)
CCAN: 109698373(Adcy7)
OCU: 100357357(ADCY7)
TUP: 102496578(ADCY7)
CFA: 487289(ADCY7)
VVP: 112929565(ADCY7)
VLG: 121497930(ADCY7)
AML: 100466965(ADCY7)
UMR: 103673916(ADCY7)
UAH: 113252223(ADCY7)
ORO: 101377421(ADCY7)
ELK: 111157326
MPUF: 101684190(ADCY7)
FCA: 101094148(ADCY7)
PTG: 102972917(ADCY7)
PPAD: 109270953(ADCY7)
AJU: 106985835(ADCY7)
HHV: 120238226(ADCY7)
BTA: 281603(ADCY7)
BOM: 102266966(ADCY7)
BIU: 109572478(ADCY7)
BBUB: 102410456(ADCY7)
CHX: 102185858(ADCY7)
OAS: 101112667(ADCY7)
ODA: 120872811(ADCY7)
SSC: 100620994(ADCY7)
CFR: 102524614(ADCY7)
CDK: 105097528(ADCY7)
BACU: 102997912(ADCY7)
LVE: 103078677(ADCY7)
OOR: 101273592(ADCY7)
DLE: 111164991(ADCY7)
PCAD: 102985075(ADCY7)
ECB: 100058891(ADCY7)
EPZ: 103556685(ADCY7)
EAI: 106824126(ADCY7)
MYB: 102253549(ADCY7)
MYD: 102764043(ADCY7)
MMYO: 118674005(ADCY7)
MNA: 107531029(ADCY7)
HAI: 109383261(ADCY7)
DRO: 112296774(ADCY7)
SHON: 119001137(ADCY7)
AJM: 119046468(ADCY7)
MMF: 118639510(ADCY7)
PALE: 102881535(ADCY7)
RAY: 107512248(ADCY7)
MJV: 108407296(ADCY7)
LAV: 100653771(ADCY7)
TMU: 101341715
MDO: 100013823(ADCY7)
SHR: 100929278(ADCY7)
PCW: 110207473(ADCY7)
OAA: 100076221(ADCY7)
GGA: 415732(ADCY7)
PCOC: 116243930(ADCY7)
MGP: 100548914
CJO: 107319017(ADCY7)
NMEL: 110404374(ADCY7)
APLA: 101794076(ADCY7)
ACYG: 106039584(ADCY7)
TGU: 100225700(ADCY7)
LSR: 110473537(ADCY7)
SCAN: 103816806(ADCY7)
PMOA: 120507978(ADCY7)
GFR: 102043194(ADCY7)
FAB: 101816007(ADCY7)
PHI: 102106688(ADCY7)
PMAJ: 107209841(ADCY7)
CCAE: 111934618(ADCY7)
CCW: 104687454(ADCY7)
ETL: 114055552(ADCY7)
FPG: 101914615(ADCY7)
FCH: 102052224(ADCY7)
CLV: 102090470(ADCY7)
EGZ: 104125176(ADCY7)
NNI: 104011289(ADCY7)
ACUN: 113484440(ADCY7)
PADL: 103913801(ADCY7)
AAM: 106483289(ADCY7)
ASN: 102368976(ADCY7)
AMJ: 102566330(ADCY7)
CPOO: 109310532(ADCY7)
GGN: 109289593(ADCY7)
PSS: 102449192(ADCY7)
CMY: 102946407(ADCY7)
CPIC: 101938536(ADCY7)
TST: 117886819(ADCY7)
CABI: 116826976(ADCY7)
ACS: 100558751(adcy7)
PVT: 110086573(ADCY7)
PBI: 103060035(ADCY7)
PMUR: 107290046(ADCY7)
TSR: 106554339(ADCY7)
PGUT: 117670935(ADCY7)
PMUA: 114602227(ADCY7)
ZVI: 118085993(ADCY7)
GJA: 107117185(ADCY7)
XLA: 399055(adcy7.L)
XTR: 100127741(adcy7)
NPR: 108794932(ADCY7)
DRE: 568726(adcy7)
IPU: 108259218(adcy7)
PHYP: 113540899(adcy7)
AMEX: 103025161(adcy7)
EEE: 113581231
TRU: 101066272(adcy7)
LCO: 104940647(adcy7)
ELY: 117253092(adcy7)
PLEP: 121939187(adcy7)
SLUC: 116037616(adcy7)
GAT: 120811617(adcy7)
MSAM: 119889811(adcy7)
MZE: 101480238(adcy7)
ONL: 100703488(adcy7)
OAU: 116325574(adcy7)
OLA: 101164967(adcy7)
OML: 112160437(adcy7)
XMA: 102223009(adcy7)
XCO: 114142861(adcy7)
XHE: 116718405(adcy7)
PRET: 103462645(adcy7)
CVG: 107088499(adcy7)
NFU: 107381237(adcy7)
KMR: 108243337(adcy7)
ALIM: 106527041
AOCE: 111572244(adcy7)
CSEM: 103398552
POV: 109625125(adcy7)
LCF: 108876970(adcy7)
SDU: 111217971(adcy7)
SLAL: 111672304(adcy7)
XGL: 120789257(adcy7)
HCQ: 109513976(adcy7)
BPEC: 110175272(adcy7)
MALB: 109955816(adcy7)
SALP: 111974474
ELS: 105025700(adcy7)
SFM: 108932972
LOC: 102689559(adcy7)
ARUT: 117424464(adcy7) 117425878
LCM: 102351065(ADCY7)
CMK: 103176081(adcy7)
RTP: 109923754
PPOT: 106100281
 » show all
Reference
PMID:7961850
  Authors
Watson PA, Krupinski J, Kempinski AM, Frankenfield CD
  Title
Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells.
  Journal
J Biol Chem 269:28893-8 (1994)
  Sequence
[hsa:113]
Reference
  Authors
Joeyen-Waldorf J, Nikolova YS, Edgar N, Walsh C, Kota R, Lewis DA, Ferrell R, Manuck SB, Hariri AR, Sibille E
  Title
Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry.
  Journal
Biol Psychiatry 71:627-32 (2012)
DOI:10.1016/j.biopsych.2011.11.029
LinkDB

KEGG   ORTHOLOGY: K08048
Entry
K08048                      KO                                     

Name
ADCY8
Definition
adenylate cyclase 8 [EC:4.6.1.1]
Pathway
ko00230  Purine metabolism
ko01100  Metabolic pathways
ko01522  Endocrine resistance
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04062  Chemokine signaling pathway
ko04072  Phospholipase D signaling pathway
ko04114  Oocyte meiosis
ko04211  Longevity regulating pathway
ko04213  Longevity regulating pathway - multiple species
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04371  Apelin signaling pathway
ko04540  Gap junction
ko04611  Platelet activation
ko04713  Circadian entrainment
ko04714  Thermogenesis
ko04720  Long-term potentiation
ko04723  Retrograde endocannabinoid signaling
ko04724  Glutamatergic synapse
ko04725  Cholinergic synapse
ko04727  GABAergic synapse
ko04742  Taste transduction
ko04750  Inflammatory mediator regulation of TRP channels
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04913  Ovarian steroidogenesis
ko04914  Progesterone-mediated oocyte maturation
ko04915  Estrogen signaling pathway
ko04916  Melanogenesis
ko04918  Thyroid hormone synthesis
ko04921  Oxytocin signaling pathway
ko04923  Regulation of lipolysis in adipocytes
ko04925  Aldosterone synthesis and secretion
ko04926  Relaxin signaling pathway
ko04927  Cortisol synthesis and secretion
ko04928  Parathyroid hormone synthesis, secretion and action
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko04970  Salivary secretion
ko04971  Gastric acid secretion
ko04972  Pancreatic secretion
ko04976  Bile secretion
ko05032  Morphine addiction
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05200  Pathways in cancer
ko05207  Chemical carcinogenesis - receptor activation
ko05414  Dilated cardiomyopathy
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09104 Nucleotide metabolism
   00230 Purine metabolism
    K08048  ADCY8; adenylate cyclase 8
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K08048  ADCY8; adenylate cyclase 8
   04371 Apelin signaling pathway
    K08048  ADCY8; adenylate cyclase 8
   04020 Calcium signaling pathway
    K08048  ADCY8; adenylate cyclase 8
   04072 Phospholipase D signaling pathway
    K08048  ADCY8; adenylate cyclase 8
   04024 cAMP signaling pathway
    K08048  ADCY8; adenylate cyclase 8
   04022 cGMP-PKG signaling pathway
    K08048  ADCY8; adenylate cyclase 8
 09140 Cellular Processes
  09143 Cell growth and death
   04114 Oocyte meiosis
    K08048  ADCY8; adenylate cyclase 8
  09144 Cellular community - eukaryotes
   04540 Gap junction
    K08048  ADCY8; adenylate cyclase 8
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    K08048  ADCY8; adenylate cyclase 8
   04062 Chemokine signaling pathway
    K08048  ADCY8; adenylate cyclase 8
  09152 Endocrine system
   04911 Insulin secretion
    K08048  ADCY8; adenylate cyclase 8
   04923 Regulation of lipolysis in adipocytes
    K08048  ADCY8; adenylate cyclase 8
   04912 GnRH signaling pathway
    K08048  ADCY8; adenylate cyclase 8
   04913 Ovarian steroidogenesis
    K08048  ADCY8; adenylate cyclase 8
   04915 Estrogen signaling pathway
    K08048  ADCY8; adenylate cyclase 8
   04914 Progesterone-mediated oocyte maturation
    K08048  ADCY8; adenylate cyclase 8
   04921 Oxytocin signaling pathway
    K08048  ADCY8; adenylate cyclase 8
   04926 Relaxin signaling pathway
    K08048  ADCY8; adenylate cyclase 8
   04935 Growth hormone synthesis, secretion and action
    K08048  ADCY8; adenylate cyclase 8
   04918 Thyroid hormone synthesis
    K08048  ADCY8; adenylate cyclase 8
   04928 Parathyroid hormone synthesis, secretion and action
    K08048  ADCY8; adenylate cyclase 8
   04916 Melanogenesis
    K08048  ADCY8; adenylate cyclase 8
   04925 Aldosterone synthesis and secretion
    K08048  ADCY8; adenylate cyclase 8
   04927 Cortisol synthesis and secretion
    K08048  ADCY8; adenylate cyclase 8
  09153 Circulatory system
   04261 Adrenergic signaling in cardiomyocytes
    K08048  ADCY8; adenylate cyclase 8
   04270 Vascular smooth muscle contraction
    K08048  ADCY8; adenylate cyclase 8
  09154 Digestive system
   04970 Salivary secretion
    K08048  ADCY8; adenylate cyclase 8
   04971 Gastric acid secretion
    K08048  ADCY8; adenylate cyclase 8
   04972 Pancreatic secretion
    K08048  ADCY8; adenylate cyclase 8
   04976 Bile secretion
    K08048  ADCY8; adenylate cyclase 8
  09156 Nervous system
   04724 Glutamatergic synapse
    K08048  ADCY8; adenylate cyclase 8
   04727 GABAergic synapse
    K08048  ADCY8; adenylate cyclase 8
   04725 Cholinergic synapse
    K08048  ADCY8; adenylate cyclase 8
   04720 Long-term potentiation
    K08048  ADCY8; adenylate cyclase 8
   04723 Retrograde endocannabinoid signaling
    K08048  ADCY8; adenylate cyclase 8
  09157 Sensory system
   04742 Taste transduction
    K08048  ADCY8; adenylate cyclase 8
   04750 Inflammatory mediator regulation of TRP channels
    K08048  ADCY8; adenylate cyclase 8
  09149 Aging
   04211 Longevity regulating pathway
    K08048  ADCY8; adenylate cyclase 8
   04213 Longevity regulating pathway - multiple species
    K08048  ADCY8; adenylate cyclase 8
  09159 Environmental adaptation
   04713 Circadian entrainment
    K08048  ADCY8; adenylate cyclase 8
   04714 Thermogenesis
    K08048  ADCY8; adenylate cyclase 8
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K08048  ADCY8; adenylate cyclase 8
   05207 Chemical carcinogenesis - receptor activation
    K08048  ADCY8; adenylate cyclase 8
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K08048  ADCY8; adenylate cyclase 8
   05163 Human cytomegalovirus infection
    K08048  ADCY8; adenylate cyclase 8
  09165 Substance dependence
   05032 Morphine addiction
    K08048  ADCY8; adenylate cyclase 8
  09166 Cardiovascular disease
   05414 Dilated cardiomyopathy
    K08048  ADCY8; adenylate cyclase 8
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K08048  ADCY8; adenylate cyclase 8
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K08048  ADCY8; adenylate cyclase 8
Enzymes [BR:ko01000]
 4. Lyases
  4.6  Phosphorus-oxygen lyases
   4.6.1  Phosphorus-oxygen lyases (only sub-subclass identified to date)
    4.6.1.1  adenylate cyclase
     K08048  ADCY8; adenylate cyclase 8
Other DBs
RN: R00089 R00434
GO: 0008294
Genes
HSA: 114(ADCY8)
PTR: 464400(ADCY8)
PPS: 100994715(ADCY8)
GGO: 101142672(ADCY8)
PON: 100461383(ADCY8)
NLE: 100592592(ADCY8)
MCC: 695792(ADCY8)
MCF: 102144854(ADCY8)
CSAB: 103237447(ADCY8)
CATY: 105588369(ADCY8)
RRO: 104675683(ADCY8)
RBB: 108514094(ADCY8)
TFN: 117079299(ADCY8)
CJC: 100404484(ADCY8)
SBQ: 101034552(ADCY8)
MMUR: 105882731(ADCY8)
MMU: 11514(Adcy8)
MCAL: 110310371(Adcy8)
MPAH: 110334612(Adcy8)
RNO: 29241(Adcy8)
MCOC: 116082049(Adcy8)
CGE: 113837458
PLEU: 114697724(Adcy8)
NGI: 103743923(Adcy8)
HGL: 101698293(Adcy8)
CCAN: 109678665(Adcy8)
OCU: 100337882(ADCY8)
TUP: 102472317(ADCY8)
CFA: 482045(ADCY8)
VVP: 112915982(ADCY8)
VLG: 121498514(ADCY8)
AML: 100474121(ADCY8)
UMR: 103661704(ADCY8)
UAH: 113252717(ADCY8)
ORO: 101370350(ADCY8)
ELK: 111146667
MPUF: 101693988(ADCY8)
EJU: 114211178(ADCY8)
FCA: 101087555(ADCY8)
PTG: 102948581(ADCY8)
PPAD: 109273118(ADCY8)
AJU: 106976879(ADCY8)
HHV: 120221853(ADCY8)
BTA: 535017(ADCY8)
BOM: 102272964(ADCY8)
BIU: 109568647(ADCY8)
BBUB: 102395302(ADCY8)
CHX: 102184919(ADCY8)
OAS: 101121944(ADCY8)
ODA: 120878868(ADCY8)
SSC: 100622999(ADCY8)
CFR: 102521259(ADCY8)
CDK: 105096450(ADCY8)
BACU: 103019172(ADCY8)
LVE: 103085845(ADCY8)
OOR: 101273171(ADCY8)
DLE: 111164400(ADCY8)
PCAD: 102975211(ADCY8)
ECB: 100057796(ADCY8)
EPZ: 103565019 103567623(ADCY8)
EAI: 106824833(ADCY8)
MYB: 102249345(ADCY8)
MYD: 102765722(ADCY8)
MMYO: 118670715(ADCY8)
MNA: 107539500(ADCY8)
HAI: 109372359(ADCY8)
DRO: 112315487(ADCY8)
SHON: 118988683(ADCY8)
AJM: 119064806(ADCY8)
MMF: 118631528(ADCY8)
PALE: 102896789(ADCY8)
RAY: 107497689(ADCY8)
MJV: 108397669(ADCY8)
LAV: 100661616(ADCY8)
TMU: 101350704
MDO: 100026554(ADCY8)
SHR: 100923926(ADCY8)
PCW: 110216073(ADCY8)
OAA: 100077908(ADCY8)
GGA: 420328(ADCY8)
PCOC: 116227752(ADCY8)
MGP: 100548951(ADCY8)
CJO: 107310566(ADCY8)
NMEL: 110394336(ADCY8)
APLA: 101794043(ADCY8)
ACYG: 106046364(ADCY8)
TGU: 100230277(ADCY8)
LSR: 110476995(ADCY8)
SCAN: 103816719(ADCY8)
PMOA: 120505202(ADCY8)
GFR: 102037430(ADCY8)
FAB: 101809046(ADCY8)
PHI: 102108193(ADCY8)
PMAJ: 107200813(ADCY8)
CCW: 104692638(ADCY8)
ETL: 114065892(ADCY8)
FPG: 101921528(ADCY8)
FCH: 102056487(ADCY8)
CLV: 102086133(ADCY8)
EGZ: 104134444(ADCY8)
NNI: 104016868(ADCY8)
ACUN: 113476386(ADCY8)
PADL: 103916382(ADCY8)
AAM: 106496221(ADCY8)
ASN: 102369910(ADCY8)
AMJ: 102562540(ADCY8)
CPOO: 109322048(ADCY8)
GGN: 109305202(ADCY8)
PSS: 102448969(ADCY8)
CMY: 102930804(ADCY8)
CPIC: 101947738(ADCY8)
TST: 117873819(ADCY8)
CABI: 116823168(ADCY8)
ACS: 100556578(adcy8)
PVT: 110090751(ADCY8)
PBI: 103049018(ADCY8)
PMUR: 107289979(ADCY8)
TSR: 106542281
PGUT: 117668453(ADCY8)
PMUA: 114600245(ADCY8)
ZVI: 118089989(ADCY8)
GJA: 107119214(ADCY8)
XLA: 108719413(adcy8.L) 414729(adcy8.S)
XTR: 549366
NPR: 108788952(ADCY8)
DRE: 100148976(adcy8) 560410(si:ch211-132f19.7) 560719(si:dkey-206f10.1)
IPU: 108257757 108280230(adcy8)
PHYP: 113532110 113543309(adcy8)
EEE: 113584128(adcy8)
LCO: 104922014 104938356(adcy8)
NCC: 104955036(adcy8)
ELY: 117250016 117270489(si:dkey-206f10.1) 117272061(adcy8)
PLEP: 121951261(adcy8) 121955835(si:dkey-206f10.1)
SLUC: 116044740(adcy8) 116066255(si:dkey-206f10.1)
GAT: 120808486
MSAM: 119901661(adcy8) 119908444 119908457(si:dkey-206f10.1) 119915897
OAU: 116310796(si:dkey-206f10.1) 116316516(adcy8) 116325033
OML: 112144246(adcy8) 112156739 112158536(si:dkey-206f10.1)
KMR: 108229092(si:ch211-132f19.7) 108246168(adcy8)
ALIM: 106527219(adcy8) 106531266
CSEM: 103380838 103396830(adcy8)
XGL: 120788729(si:dkey-206f10.1) 120798356 120799361(adcy8)
HCQ: 109518125 109518881(adcy8)
BPEC: 110155800 110165875(adcy8)
MALB: 109970259(adcy8) 109971087
SASA: 106568630(adcy8) 106611404
OTW: 112250071(adcy8) 112255820
OMY: 110504263(si:ch211-132f19.7) 110529931(adcy8)
SALP: 111957123(adcy8) 112076728
ELS: 105023619(adcy8) 105031560
SFM: 108918520 108937764(adcy8)
PKI: 111845896(adcy8)
LOC: 102685748(adcy8) 102694194
PSPA: 121309014(adcy8)
ARUT: 117399547(adcy8)
LCM: 102346737(ADCY8)
CMK: 103183440(adcy8)
RTP: 109914598(adcy8)
BFO: 118405038
CIN: 100181005
SCLV: 120336024
SKO: 100370378
DME: Dmel_CG10564(Ac78C)
DER: 6546178
DSE: 6616399
DSI: Dsimw501_GD12142(Dsim_GD12142)
DAN: 6493061
DSR: 110189946
DPE: 6602992
DMN: 108152936
DWI: 6645098
DNV: 108652084
DHE: 111599815
DVI: 6623758
MDE: 101893364
LCQ: 111677112
ACOZ: 120949475
AARA: 120894424
AAG: 5563558
AALB: 109414810
CPII: 120415895
AME: 726262
BIM: 100741339
BTER: 100650732
CCAL: 108626074
OBB: 114874916
MGEN: 117228046
SOC: 105208160
MPHA: 105831878
AEC: 105145442
ACEP: 105621896
PBAR: 105425253
VEM: 105566125
HST: 105185447
DQU: 106740959
CFO: 105247922
FEX: 115242516
LHU: 105672367
PGC: 109856473
OBO: 105279868
PCF: 106787929
NVI: 100679362
CSOL: 105367908
MDL: 103569316
DPA: 109539855
ATD: 109600572
AGB: 108912049
NVL: 108558843
PPYR: 116169542
OTU: 111419609
BMOR: 101744252
BMAN: 114249948
MSEX: 115448811
PMAC: 106707822
PPOT: 106111023
PXU: 106114758
PRAP: 110992313
ZCE: 119829857
PXY: 105382561
API: 100161699
DNX: 107163062
AGS: 114123034
RMD: 113561352
BTAB: 109032361
DCI: 103516636
CLEC: 106663679
NLU: 111044266
ZNE: 110834851
CSEC: 111865456
FCD: 110854056
PVM: 113803537
EAF: 111704198
DSV: 119448858
RSAN: 119381807
RMP: 119170587
TUT: 107365159
DPTE: 113796993
PTEP: 107439048
SDM: 118184219
PMAX: 117316821
LAK: 106153878
AQU: 100637659
DFA: DFA_04345(acaA)
SPAR: SPRG_05070
 » show all
Reference
PMID:8076676
  Authors
Defer N, Marinx O, Stengel D, Danisova A, Iourgenko V, Matsuoka I, Caput D, Hanoune J
  Title
Molecular cloning of the human type VIII adenylyl cyclase.
  Journal
FEBS Lett 351:109-13 (1994)
DOI:10.1016/0014-5793(94)00836-1
  Sequence
[hsa:114]
Reference
  Authors
Roger B, Papin J, Vacher P, Raoux M, Mulot A, Dubois M, Kerr-Conte J, Voy BH, Pattou F, Charpentier G, Jonas JC, Moustaid-Moussa N, Lang J
  Title
Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells.
  Journal
Diabetologia 54:390-402 (2011)
DOI:10.1007/s00125-010-1955-x
LinkDB

KEGG   ORTHOLOGY: K08049
Entry
K08049                      KO                                     

Name
ADCY9
Definition
adenylate cyclase 9 [EC:4.6.1.1]
Pathway
ko00230  Purine metabolism
ko01100  Metabolic pathways
ko01522  Endocrine resistance
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04062  Chemokine signaling pathway
ko04072  Phospholipase D signaling pathway
ko04114  Oocyte meiosis
ko04211  Longevity regulating pathway
ko04213  Longevity regulating pathway - multiple species
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04361  Axon regeneration
ko04371  Apelin signaling pathway
ko04540  Gap junction
ko04611  Platelet activation
ko04713  Circadian entrainment
ko04714  Thermogenesis
ko04723  Retrograde endocannabinoid signaling
ko04724  Glutamatergic synapse
ko04725  Cholinergic synapse
ko04727  GABAergic synapse
ko04750  Inflammatory mediator regulation of TRP channels
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04913  Ovarian steroidogenesis
ko04914  Progesterone-mediated oocyte maturation
ko04915  Estrogen signaling pathway
ko04916  Melanogenesis
ko04918  Thyroid hormone synthesis
ko04921  Oxytocin signaling pathway
ko04923  Regulation of lipolysis in adipocytes
ko04925  Aldosterone synthesis and secretion
ko04926  Relaxin signaling pathway
ko04927  Cortisol synthesis and secretion
ko04928  Parathyroid hormone synthesis, secretion and action
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko04961  Endocrine and other factor-regulated calcium reabsorption
ko04962  Vasopressin-regulated water reabsorption
ko04970  Salivary secretion
ko04971  Gastric acid secretion
ko04972  Pancreatic secretion
ko04976  Bile secretion
ko05032  Morphine addiction
ko05110  Vibrio cholerae infection
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05200  Pathways in cancer
ko05207  Chemical carcinogenesis - receptor activation
ko05414  Dilated cardiomyopathy
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09104 Nucleotide metabolism
   00230 Purine metabolism
    K08049  ADCY9; adenylate cyclase 9
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K08049  ADCY9; adenylate cyclase 9
   04371 Apelin signaling pathway
    K08049  ADCY9; adenylate cyclase 9
   04020 Calcium signaling pathway
    K08049  ADCY9; adenylate cyclase 9
   04072 Phospholipase D signaling pathway
    K08049  ADCY9; adenylate cyclase 9
   04024 cAMP signaling pathway
    K08049  ADCY9; adenylate cyclase 9
   04022 cGMP-PKG signaling pathway
    K08049  ADCY9; adenylate cyclase 9
 09140 Cellular Processes
  09143 Cell growth and death
   04114 Oocyte meiosis
    K08049  ADCY9; adenylate cyclase 9
  09144 Cellular community - eukaryotes
   04540 Gap junction
    K08049  ADCY9; adenylate cyclase 9
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    K08049  ADCY9; adenylate cyclase 9
   04062 Chemokine signaling pathway
    K08049  ADCY9; adenylate cyclase 9
  09152 Endocrine system
   04911 Insulin secretion
    K08049  ADCY9; adenylate cyclase 9
   04923 Regulation of lipolysis in adipocytes
    K08049  ADCY9; adenylate cyclase 9
   04912 GnRH signaling pathway
    K08049  ADCY9; adenylate cyclase 9
   04913 Ovarian steroidogenesis
    K08049  ADCY9; adenylate cyclase 9
   04915 Estrogen signaling pathway
    K08049  ADCY9; adenylate cyclase 9
   04914 Progesterone-mediated oocyte maturation
    K08049  ADCY9; adenylate cyclase 9
   04921 Oxytocin signaling pathway
    K08049  ADCY9; adenylate cyclase 9
   04926 Relaxin signaling pathway
    K08049  ADCY9; adenylate cyclase 9
   04935 Growth hormone synthesis, secretion and action
    K08049  ADCY9; adenylate cyclase 9
   04918 Thyroid hormone synthesis
    K08049  ADCY9; adenylate cyclase 9
   04928 Parathyroid hormone synthesis, secretion and action
    K08049  ADCY9; adenylate cyclase 9
   04916 Melanogenesis
    K08049  ADCY9; adenylate cyclase 9
   04925 Aldosterone synthesis and secretion
    K08049  ADCY9; adenylate cyclase 9
   04927 Cortisol synthesis and secretion
    K08049  ADCY9; adenylate cyclase 9
  09153 Circulatory system
   04261 Adrenergic signaling in cardiomyocytes
    K08049  ADCY9; adenylate cyclase 9
   04270 Vascular smooth muscle contraction
    K08049  ADCY9; adenylate cyclase 9
  09154 Digestive system
   04970 Salivary secretion
    K08049  ADCY9; adenylate cyclase 9
   04971 Gastric acid secretion
    K08049  ADCY9; adenylate cyclase 9
   04972 Pancreatic secretion
    K08049  ADCY9; adenylate cyclase 9
   04976 Bile secretion
    K08049  ADCY9; adenylate cyclase 9
  09155 Excretory system
   04962 Vasopressin-regulated water reabsorption
    K08049  ADCY9; adenylate cyclase 9
   04961 Endocrine and other factor-regulated calcium reabsorption
    K08049  ADCY9; adenylate cyclase 9
  09156 Nervous system
   04724 Glutamatergic synapse
    K08049  ADCY9; adenylate cyclase 9
   04727 GABAergic synapse
    K08049  ADCY9; adenylate cyclase 9
   04725 Cholinergic synapse
    K08049  ADCY9; adenylate cyclase 9
   04723 Retrograde endocannabinoid signaling
    K08049  ADCY9; adenylate cyclase 9
  09157 Sensory system
   04750 Inflammatory mediator regulation of TRP channels
    K08049  ADCY9; adenylate cyclase 9
  09158 Development and regeneration
   04361 Axon regeneration
    K08049  ADCY9; adenylate cyclase 9
  09149 Aging
   04211 Longevity regulating pathway
    K08049  ADCY9; adenylate cyclase 9
   04213 Longevity regulating pathway - multiple species
    K08049  ADCY9; adenylate cyclase 9
  09159 Environmental adaptation
   04713 Circadian entrainment
    K08049  ADCY9; adenylate cyclase 9
   04714 Thermogenesis
    K08049  ADCY9; adenylate cyclase 9
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K08049  ADCY9; adenylate cyclase 9
   05207 Chemical carcinogenesis - receptor activation
    K08049  ADCY9; adenylate cyclase 9
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K08049  ADCY9; adenylate cyclase 9
   05163 Human cytomegalovirus infection
    K08049  ADCY9; adenylate cyclase 9
  09171 Infectious disease: bacterial
   05110 Vibrio cholerae infection
    K08049  ADCY9; adenylate cyclase 9
  09165 Substance dependence
   05032 Morphine addiction
    K08049  ADCY9; adenylate cyclase 9
  09166 Cardiovascular disease
   05414 Dilated cardiomyopathy
    K08049  ADCY9; adenylate cyclase 9
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K08049  ADCY9; adenylate cyclase 9
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K08049  ADCY9; adenylate cyclase 9
Enzymes [BR:ko01000]
 4. Lyases
  4.6  Phosphorus-oxygen lyases
   4.6.1  Phosphorus-oxygen lyases (only sub-subclass identified to date)
    4.6.1.1  adenylate cyclase
     K08049  ADCY9; adenylate cyclase 9
Other DBs
RN: R00089 R00434
GO: 0004016
Genes
HSA: 115(ADCY9)
PTR: 453869(ADCY9)
PPS: 100972356(ADCY9)
GGO: 101145410(ADCY9)
PON: 103889530(ADCY9)
NLE: 100599484(ADCY9)
MCC: 706789(ADCY9)
MCF: 102135189 102135923(ADCY9)
CSAB: 103227576(ADCY9)
CATY: 105572097(ADCY9)
RRO: 104672288(ADCY9)
RBB: 108538326(ADCY9)
TFN: 117097725(ADCY9)
CJC: 100405403(ADCY9)
SBQ: 101052034(ADCY9)
MMUR: 105859653(ADCY9)
MMU: 11515(Adcy9)
MCAL: 110311555(Adcy9)
MPAH: 110329624(Adcy9)
RNO: 302950(Adcy9)
MCOC: 116084214(Adcy9)
MUN: 110545944(Adcy9)
CGE: 100751372(Adcy9)
PLEU: 114710615(Adcy9)
NGI: 103744458(Adcy9)
HGL: 101714605(Adcy9)
OCU: 100340877(ADCY9)
TUP: 102477344(ADCY9)
CFA: 490031(ADCY9)
VVP: 112923266(ADCY9)
VLG: 121486234(ADCY9)
AML: 100476495(ADCY9)
UMR: 103668547(ADCY9)
UAH: 113270857(ADCY9)
ORO: 101364108(ADCY9)
ELK: 111156133
MPUF: 101680942(ADCY9)
EJU: 114219898(ADCY9)
FCA: 101095942(ADCY9)
PTG: 102969003(ADCY9)
PPAD: 109278247(ADCY9)
AJU: 106978803(ADCY9)
HHV: 120236476(ADCY9)
BTA: 525482(ADCY9)
BOM: 102285642(ADCY9)
BIU: 109578364(ADCY9)
BBUB: 102404282(ADCY9)
CHX: 102188104(ADCY9)
OAS: 101122401(ADCY9)
ODA: 120874335(ADCY9)
SSC: 100625423(ADCY9)
CFR: 102505261(ADCY9)
CDK: 105099828(ADCY9)
BACU: 103016058(ADCY9)
LVE: 103070451(ADCY9)
OOR: 101281654(ADCY9)
DLE: 111185250(ADCY9)
PCAD: 102995803(ADCY9)
ECB: 100066046(ADCY9)
EPZ: 103553014(ADCY9)
EAI: 106826021(ADCY9)
MYB: 102248953(ADCY9)
MYD: 102760324(ADCY9)
MMYO: 118656939(ADCY9)
MNA: 107535777(ADCY9)
HAI: 109392133(ADCY9)
DRO: 112298360(ADCY9)
SHON: 118975805(ADCY9)
AJM: 119056281(ADCY9)
MMF: 118642221(ADCY9)
PALE: 102885676(ADCY9)
RAY: 107521680(ADCY9)
MJV: 108384867 108406458(ADCY9)
LAV: 100663448(ADCY9)
TMU: 101344705
MDO: 100013831(ADCY9)
SHR: 100926025(ADCY9)
PCW: 110214660(ADCY9)
OAA: 100080569(ADCY9)
GGA: 395339(ADCY9)
PCOC: 116230251(ADCY9)
CJO: 107320968(ADCY9)
NMEL: 110405807(ADCY9)
APLA: 101800617(ADCY9)
ACYG: 106033354(ADCY9)
TGU: 100231171(ADCY9)
LSR: 110476108(ADCY9)
SCAN: 103817765(ADCY9)
PMOA: 120513041(ADCY9)
GFR: 102043312(ADCY9)
FAB: 101818533(ADCY9)
PHI: 102103610(ADCY9)
PMAJ: 107211136(ADCY9)
CCAE: 111935874(ADCY9)
CCW: 104684954(ADCY9)
ETL: 114057021(ADCY9)
FPG: 101921768(ADCY9)
FCH: 102047847(ADCY9)
CLV: 102095574(ADCY9)
EGZ: 104121973(ADCY9)
NNI: 104023465(ADCY9)
ACUN: 113485514(ADCY9)
PADL: 103917604(ADCY9)
AAM: 106482327(ADCY9)
ASN: 102370673 102373860(ADCY9)
AMJ: 102574362(ADCY9)
CPOO: 109313447(ADCY9)
GGN: 109290787(ADCY9)
PSS: 102448197(ADCY9)
CMY: 102945804(ADCY9)
CPIC: 101940138(ADCY9)
TST: 117883930(ADCY9)
CABI: 116825535(ADCY9)
ACS: 100556223(adcy9)
PVT: 110089110(ADCY9)
PBI: 103051661(ADCY9)
PMUR: 107283963(ADCY9)
TSR: 106551564(ADCY9)
PGUT: 117679454(ADCY9)
PMUA: 114584296(ADCY9)
ZVI: 118092905(ADCY9)
GJA: 107109291(ADCY9)
XLA: 108703189(adcy9.S) 378610(adcy9.L)
XTR: 100126441(adcy9)
NPR: 108790811(ADCY9)
DRE: 100333702(adcy9) 101884360
CCAR: 109046870 109046899(adcy9)
IPU: 108259388(adcy9)
PHYP: 113547577
AMEX: 103022434(adcy9)
TRU: 101074204 101078598(adcy9)
LCO: 104925375 104925703(adcy9)
ELY: 117255130(adcy9) 117268794
PLEP: 121941820(adcy9) 121956605
SLUC: 116042792(adcy9) 116059342
GAT: 120825138(adcy9) 120827674
MSAM: 119889816 119899433(adcy9)
MZE: 101466373 101477119(adcy9)
ONL: 100703903(adcy9) 100710254
OAU: 116310579(adcy9) 116321439
OLA: 101155516(adcy9) 101163149
OML: 112137465(adcy9) 112146809
XMA: 102230840(adcy9) 102231255
XCO: 114144541 114160082(adcy9)
XHE: 116719875 116735712(adcy9)
PRET: 103464021 103469190(adcy9)
CVG: 107083431 107095220(adcy9)
NFU: 107376487(adcy9) 107390534
KMR: 108241462(adcy9) 108247648
ALIM: 106518708(adcy9) 106532502
CSEM: 103384091 103393051(adcy9)
LCF: 108885408 108886159(adcy9)
SDU: 111227004(adcy9) 111229246
SLAL: 111665544 111667563(adcy9)
XGL: 120783409 120799900(adcy9)
HCQ: 109527326 109532550(adcy9)
BPEC: 110166178 110168281(adcy9)
MALB: 109972278 109972902(adcy9)
SALP: 112074752
SFM: 108928849(adcy9) 108930202
PKI: 111843208(adcy9) 111860576
LOC: 102695743(adcy9)
ARUT: 117418288 117431652(adcy9)
LCM: 102363182(ADCY9)
CMK: 103178726(adcy9)
RTP: 109913552 109932682(adcy9)
BFO: 118419128
CIN: 100176999
SCLV: 120340982
SPU: 115918037
APLC: 110976938
DME: Dmel_CG9210(Ac13E)
DER: 6550781
DSE: 6620492
DSI: Dsimw501_GD27717(Dsim_GD27717)
DAN: 6504918
DSR: 110179465
DPE: 6600185
DMN: 108162824
DWI: 6641108
DAZ: 108618258
DNV: 108657257
DHE: 111593022
DVI: 6632141
MDE: 101898652
LCQ: 111674878
ACOZ: 120960963
AARA: 120905622
AAG: 23687681
AALB: 109401910
CPII: 120416886
AME: 552535
BIM: 100746561
BTER: 100651494
CCAL: 108624324
OBB: 114880536
MGEN: 117225285
NMEA: 116429546
SOC: 105198643
MPHA: 105838352
AEC: 105150701
ACEP: 105627205
PBAR: 105427028
VEM: 105564754
HST: 105181099
DQU: 106747283
CFO: 105256088
FEX: 115243591
LHU: 105677518
PGC: 109854881
PCF: 106790513
NVI: 100119583
CSOL: 105363461
MDL: 103571696
TCA: 663450
ATD: 109602330
AGB: 108914929
NVL: 108565010
APLN: 108738447
PPYR: 116177917
BMOR: 101739269
BMAN: 114241715
PMAC: 106721760
PPOT: 106103338
PXU: 106123447
PRAP: 110992828
ZCE: 119833421
HAW: 110378429
TNL: 113507970
PXY: 105390863
BTAB: 109032478
CLEC: 106670008
NLU: 111052708
ZNE: 110827835
CSEC: 111861375
PVM: 113829994
EAF: 111705863
DSV: 119449545
RSAN: 119382569
RMP: 119179607
VDE: 111243249
CSCU: 111635808
CEL: CELE_F17C8.1(acy-1)
CBR: CBG18000(Cbr-acy-1)
BMY: BM_BM3414(Bma-acy-1)
PCAN: 112558934
BGT: 106058937
GAE: 121375216
CRG: 105335675
MYI: 110461839
PMAX: 117329864
NVE: 5519173
EPA: 110248954
ATEN: 116296067
ADF: 107348722
AMIL: 114950775
PDAM: 113676812
SPIS: 111327491
DGT: 114524446
AQU: 100641421
 » show all
Reference
PMID:9628827
  Authors
Hacker BM, Tomlinson JE, Wayman GA, Sultana R, Chan G, Villacres E, Disteche C, Storm DR
  Title
Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9).
  Journal
Genomics 50:97-104 (1998)
DOI:10.1006/geno.1998.5293
  Sequence
[hsa:115]
LinkDB

KEGG   ORTHOLOGY: K11265
Entry
K11265                      KO                                     

Name
ADCY10
Definition
adenylate cyclase 10 [EC:4.6.1.1]
Pathway
ko00230  Purine metabolism
ko01100  Metabolic pathways
ko04024  cAMP signaling pathway
ko04371  Apelin signaling pathway
ko04713  Circadian entrainment
ko04714  Thermogenesis
ko04935  Growth hormone synthesis, secretion and action
Disease
H02340  Absorptive hypercalciuria
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09104 Nucleotide metabolism
   00230 Purine metabolism
    K11265  ADCY10; adenylate cyclase 10
 09130 Environmental Information Processing
  09132 Signal transduction
   04371 Apelin signaling pathway
    K11265  ADCY10; adenylate cyclase 10
   04024 cAMP signaling pathway
    K11265  ADCY10; adenylate cyclase 10
 09150 Organismal Systems
  09152 Endocrine system
   04935 Growth hormone synthesis, secretion and action
    K11265  ADCY10; adenylate cyclase 10
  09159 Environmental adaptation
   04713 Circadian entrainment
    K11265  ADCY10; adenylate cyclase 10
   04714 Thermogenesis
    K11265  ADCY10; adenylate cyclase 10
Enzymes [BR:ko01000]
 4. Lyases
  4.6  Phosphorus-oxygen lyases
   4.6.1  Phosphorus-oxygen lyases (only sub-subclass identified to date)
    4.6.1.1  adenylate cyclase
     K11265  ADCY10; adenylate cyclase 10
Other DBs
RN: R00089 R00434
GO: 0004016
Genes
HSA: 55811(ADCY10)
PTR: 462679 469570(ADCY10)
PPS: 100974597(ADCY10)
GGO: 101137507(ADCY10)
PON: 100459701(ADCY10)
NLE: 100601811(ADCY10)
MCC: 698566(ADCY10) 719662
MCF: 101925738(ADCY10) 102134704
CSAB: 103221530 103230649(ADCY10)
CATY: 105592084 105600195(ADCY10)
RRO: 104668974(ADCY10)
RBB: 108526738(ADCY10)
TFN: 117075144(ADCY10) 117087180
CJC: 100411024(ADCY10)
SBQ: 101048632(ADCY10)
MMUR: 105869145 105881883(ADCY10)
MMU: 271639(Adcy10)
MCAL: 110284653(Adcy10)
MPAH: 110321722(Adcy10)
RNO: 59320(Adcy10)
MCOC: 116102837(Adcy10)
MUN: 110561746(Adcy10)
CGE: 100767272(Adcy10)
PLEU: 114689930(Adcy10)
CCAN: 109696039(Adcy10)
OCU: 100008902(ADCY10) 100348238
CFA: 480087(ADCY10)
VVP: 112914158 112923501(ADCY10)
VLG: 121474318 121495778(ADCY10)
AML: 100467117(ADCY10) 100468881
UMR: 103667527(ADCY10)
UAH: 113261044 113262877(ADCY10)
ORO: 101363792 101379936(ADCY10)
MPUF: 101674047(ADCY10) 101679208
EJU: 114204463 114215584(ADCY10)
FCA: 101090105 101099099(ADCY10)
PTG: 102960312(ADCY10) 102963294
PPAD: 109251769(ADCY10) 109271587
AJU: 106966216(ADCY10) 106985419
HHV: 120238262(ADCY10) 120238725
BTA: 521844(ADCY10) 531747
BOM: 102282921(ADCY10)
BIU: 109577377 109577577(ADCY10)
BBUB: 102399180 102408159(ADCY10)
CHX: 102173054(ADCY10) 102188365
OAS: 101108001 101111248(ADCY10)
ODA: 120855478(ADCY10) 120870145
SSC: 100157188(ADCY10) 100737927
CFR: 102504883 102505256(ADCY10)
CDK: 105086742 105092727(ADCY10)
BACU: 103004098(ADCY10) 103012311
LVE: 103068449 103087922(ADCY10)
OOR: 101282314(ADCY10)
DLE: 111167330(ADCY10) 111178792
PCAD: 102978052(ADCY10) 102995948
ECB: 100056933(ADCY10) 100066125
EPZ: 103551549(ADCY10) 103555495
EAI: 106824540 106841554(ADCY10)
MYB: 102245584(ADCY10)
MYD: 102756206(ADCY10)
MMYO: 118660771 118673662(ADCY10)
MNA: 107529078(ADCY10)
DRO: 112297116(ADCY10)
SHON: 118979167(ADCY10) 118991198
MMF: 118621363 118637012(ADCY10)
PALE: 102889468(ADCY10)
RAY: 107499090 107512745(ADCY10)
LAV: 100655094(ADCY10)
TMU: 101355469
MDO: 100018346(ADCY10)
SHR: 100913418(ADCY10)
PCW: 110199732(ADCY10)
OAA: 100083210(ADCY10)
GGA: 100858603(ADCY10L8) 101749972(ADCY10L11) 101752207(ADCY10L6) 770187(ADCY10L3)
MGP: 104915647
CJO: 107306395
NMEL: 110390200
APLA: 113843545
NNI: 104011887(ADCY10)
AAM: 106493891
ASN: 102375844(ADCY10)
AMJ: 102575865(ADCY10)
CPOO: 109307134(ADCY10) 109317795
GGN: 109287003(ADCY10) 109295378
PSS: 102463064(ADCY10)
CMY: 102946780(ADCY10)
CABI: 116818152 116839866(ADCY10)
ACS: 100551626(adcy10)
PVT: 110089348(ADCY10)
PMUR: 107302841(ADCY10)
PGUT: 117661240(ADCY10)
PMUA: 114598412(ADCY10)
ZVI: 118089150(ADCY10)
GJA: 107117510
OMY: 110528803
LOC: 102694164(adcy10)
PSPA: 121321955
ARUT: 117426684
BFO: 118420511
CIN: 100181520
SCLV: 120337938
SPU: 574069
ACOZ: 120956774
AARA: 120903431
AAG: 5574681
AALB: 109420928
FEX: 115241315
NVI: 100114731
TCA: 655059
OTU: 111420845
NLU: 111054281
DSV: 119455927
RSAN: 119394217
RMP: 119172912
SDM: 118184600
PMAX: 117323174
ATEN: 116294343
 » show all
Reference
  Authors
Geng W, Wang Z, Zhang J, Reed BY, Pak CY, Moe OW
  Title
Cloning and characterization of the human soluble adenylyl cyclase.
  Journal
Am J Physiol Cell Physiol 288:C1305-16 (2005)
DOI:10.1152/ajpcell.00584.2004
  Sequence
[hsa:55811]
LinkDB

DBGET integrated database retrieval system